- Monday, October 17, 2022
7:00 AM – 8:30 AM ET
Exploring funding opportunities and considerations within current capital markets
7:00 AM – 8:30 AM ET
Exploring Funding Opportunities and Considerations Within Current Capital MarketsLocation:153 BCModerator: – Rutgers University
Executive Education Speaker: – Ampersand Capital Partners
Executive Education Speaker: – EverGlade Consulting
Executive Education Speaker: – Nevakar, Inc
Patrick J. Sinko, PhD – Rutgers University ### 602328###Moderator###Distinguished Professor###Rutgers University###Moderator: – Rutgers University
### @@@ Dave Patteson – Ampersand Capital Partners ### 1794643###Executive Education Speaker###Partner###Ampersand Capital Partners###Executive Education Speaker: – Ampersand Capital Partners
### @@@ Andrew Stiles – EverGlade Consulting ### 1779402###Executive Education Speaker###Principal###EverGlade Consulting###Executive Education Speaker: – EverGlade Consulting
### @@@ Navneet Puri, PhD (he/him/his) – Nevakar, Inc ### 1794644###Executive Education Speaker###Chairman, Founder & President###Nevakar, Inc###Executive Education Speaker: – Nevakar, Inc
### he/him/his7:30 AM – 8:30 AM ET
The Journals of AAPS Editorial Board Breakfast (by invitation only)
7:30 AM – 8:30 AM ET
The Journals of AAPS Editorial Board Breakfast (by invitation only)Location:Douglas Room, Westin Boston Seaport District Hotel
7:30 AM – 5:00 PM ET
Registration Hours
7:30 AM – 5:00 PM ET
Registration Hours
Location:North Lobby
7:30 AM – 5:00 PM ET
Speaker Ready Room
7:30 AM – 5:00 PM ET
Speaker Ready Room
Location:252 AB
8:30 AM – 9:00 AM ET
Prologue: An Evolving Biologics Landscape Driving Innovation and OptimizationPrologue Speaker: – Merck
Preclinical Development – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: An Evolving Biologics Landscape Driving Innovation and OptimizationLocation:254 APrologue Speaker: – Merck
Preclinical Development – Biomolecular
Robert S. Foti, PhD – Merck ### 1759594###Prologue Speaker###Senior Director - Bioanalysis, ADME & Discovery Toxicology###Merck###Prologue Speaker: – Merck
### 8:30 AM – 9:00 AM ET
Prologue: Analytical Challenges for Biomolecules Prologue Speaker: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Analytical Challenges for Biomolecules Location:205 CPrologue Speaker: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
Paul Logan Walsh, PhD – AbbVie ### 846991###Prologue Speaker###Director###AbbVie###Prologue Speaker: – AbbVie
### 8:30 AM – 9:00 AM ET
Prologue: Can Computers Accelerate the Discovery of New Drugs? Comments From a Sarcastic but Optimistic Computational ChemistPrologue Speaker: – University of North Carolina
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: Can Computers Accelerate the Discovery of New Drugs? Comments From a Sarcastic but Optimistic Computational ChemistLocation:254 BPrologue Speaker: – University of North Carolina
Discovery and Basic Research
Alexander Tropsha, PhD – University of North Carolina ### 1695022###Prologue Speaker###KH Lee Distinguished Professor###University of North Carolina ###Prologue Speaker: – University of North Carolina
### 8:30 AM – 9:00 AM ET
Prologue: Challenges and Opportunities During COVID-19 Pandemic and its Impact on Clinical Trials: A Clinical Pharmacology PerspectivePrologue Speaker: – Gilead Sciences
Clinical Pharmacology – Chemical
8:30 AM – 9:00 AM ET
Prologue: Challenges and Opportunities During COVID-19 Pandemic and its Impact on Clinical Trials: A Clinical Pharmacology PerspectiveLocation:151 ABPrologue Speaker: – Gilead Sciences
Clinical Pharmacology – Chemical
Sandhya Girish, M.Pharm, PhD – Gilead Sciences ### 1718494###Prologue Speaker###Vice President, Head Clinical Pharmacology, Bioanalytical & Pharmacometrics###Gilead Sciences###Prologue Speaker: – Gilead Sciences
### 8:30 AM – 9:00 AM ET
Prologue: Immunogenicity of AAV Vectors in Gene TherapyGovernment Speaker: – U.S. Food and Drug Administration
Bioanalytics – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Immunogenicity of AAV Vectors in Gene TherapyLocation:253 BGovernment Speaker: – U.S. Food and Drug Administration
Bioanalytics – Biomolecular
Ronit Mazor, Ph.D. – U.S. Food and Drug Administration ### 1216533###Government Speaker###Principal investigator, Gene Transfer and Immunogenicity Branch###U.S. Food and Drug Administration###Government Speaker: – U.S. Food and Drug Administration
### 8:30 AM – 9:00 AM ET
Prologue: Modeling and Predictive Design in Pharmaceutical DevelopmentManufacturing & Analytical Characterization – Chemical
8:30 AM – 9:00 AM ET
Prologue: Modeling and Predictive Design in Pharmaceutical DevelopmentLocation:206 ABManufacturing & Analytical Characterization – Chemical
Sayantan Chattoraj, Ph.D. – GSK ### 828674###Prologue Speaker###Director & GSK Fellow, Drug Product Development###GSK###Prologue Speaker: – GSK
### 8:30 AM – 9:00 AM ET
Prologue: Pharmacokinetics and Interaction Implications for LNP TherapyPrologue Speaker: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Pharmacokinetics and Interaction Implications for LNP TherapyLocation:204 ABPrologue Speaker: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
Douglas Burdette, Ph.D. – Moderna Therapeutics ### 1718882###Prologue Speaker###Director, DMPK###Moderna Therapeutics###Prologue Speaker: – Moderna Therapeutics
### 8:30 AM – 9:00 AM ET
Prologue: PRiME: A Vision for Accelerating Academic Drug DiscoveryPrologue Speaker: – University of Toronto
Preclinical Development – Chemical
8:30 AM – 9:00 AM ET
Prologue: PRiME: A Vision for Accelerating Academic Drug DiscoveryLocation:253 CPrologue Speaker: – University of Toronto
Preclinical Development – Chemical
Carolyn Cummins, Ph.D. – University of Toronto ### 1446757###Prologue Speaker###Associate Professor###University of Toronto###Prologue Speaker: – University of Toronto
### 8:30 AM – 9:00 AM ET
Prologue: Smaliobiotideocules: Where Do Small Molecules End and Large Molecules Start?Prologue Speaker: – Veloxity Labs, LLC
Bioanalytics – Chemical
8:30 AM – 9:00 AM ET
Prologue: Smaliobiotideocules: Where Do Small Molecules End and Large Molecules Start?Location:253 APrologue Speaker: – Veloxity Labs, LLC
Bioanalytics – Chemical
Shane Needham, Ph.D. – Veloxity Labs, LLC ### 1611936###Prologue Speaker###Founder, President and CEO###Veloxity Labs, LLC###Prologue Speaker: – Veloxity Labs, LLC
### 8:30 AM – 9:00 AM ET
Prologue: Systems and Clinical Pharmacology of Covid-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective Prologue Speaker: – University of Washington
Clinical Pharmacology – Biomolecular
8:30 AM – 9:00 AM ET
Prologue: Systems and Clinical Pharmacology of Covid-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective Location:152Prologue Speaker: – University of Washington
Clinical Pharmacology – Biomolecular
Simone Perazzolo, PhD – University of Washington ### 1695214###Prologue Speaker###Scientist###University of Washington###Prologue Speaker: – University of Washington
### 8:30 AM – 9:00 AM ET
Prologue: The Elimination of Biochemical and Immunological Barriers in the Tumor Microenvironment to Improve Cancer ImmunotherapyPrologue Speaker: – Northeastern University
Discovery and Basic Research
8:30 AM – 9:00 AM ET
Prologue: The Elimination of Biochemical and Immunological Barriers in the Tumor Microenvironment to Improve Cancer ImmunotherapyLocation:255Prologue Speaker: – Northeastern University
Discovery and Basic Research
Stephen Hatfield, PhD – Northeastern University ### 1691763###Prologue Speaker###Assistant Professor###Northeastern University ###Prologue Speaker: – Northeastern University
### 8:30 AM – 4:00 PM ET
Guest Tour: The North Shore of Boston (additional fee required)
8:30 AM – 4:00 PM ET
Guest Tour: The North Shore of Boston (additional fee required)Location:Meet in Lobby of Westin at 8:45 am
8:30 AM – 4:30 PM ET
Coffee Station
8:30 AM – 4:30 PM ET
Coffee StationLocation:Booth #1344, Exhibit Hall A&B
8:30 AM – 4:30 PM ET
Free Professional Headshots
8:30 AM – 4:30 PM ET
Free Professional HeadshotsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 4:30 PM ET
LinkedIn Profile Critiques & Resume Reviews
8:30 AM – 4:30 PM ET
LinkedIn Profile Critiques & Resume ReviewsLocation:Career Development Center, Exhibit Hall A&B
8:30 AM – 5:00 PM ET
Solution Center Hours & Poster Presentations
8:30 AM – 5:00 PM ET
Solution Center Hours & Poster PresentationsLocation:Exhibit Hall A&B
9:00 AM – 10:00 AM ET
Hot Topic: Current Learnings From Diverse Global Immune Responses to COVID-19 VaccinesHot Topic Speaker: – Mercer University
Hot Topic Speaker: – Mercer University College of Pharmacy
Hot Topic Moderator: – Moderna Therapeutics
Discovery and Basic Research
9:00 AM – 10:00 AM ET
Hot Topic: Current Learnings From Diverse Global Immune Responses to COVID-19 VaccinesLocation:153 AHot Topic Speaker: – Mercer University
Hot Topic Speaker: – Mercer University College of Pharmacy
Hot Topic Moderator: – Moderna Therapeutics
Discovery and Basic Research
Sharon Vijayanand, B. Pharm – Mercer University ### 1045775###Hot Topic Speaker###Ph.D. Candidate###Mercer University###Hot Topic Speaker: – Mercer University
### @@@ Smital R. Patil, Bachelor of Pharmacy – Mercer University College of Pharmacy ### 1045776###Hot Topic Speaker###Ph.D Candidate###Mercer University College of Pharmacy###Hot Topic Speaker: – Mercer University College of Pharmacy
### @@@ Satish Singh – Moderna Therapeutics ### 1650363###Hot Topic Moderator###Vice President###Moderna Therapeutics###Hot Topic Moderator: – Moderna Therapeutics
### 9:00 AM – 10:00 AM ET
The Skills You Need to be a Pharmaceutical ConsultantCareer Center Moderator: – Certara
Career Center Moderator: – Certara
Career Center Speaker: – Certara
Career Center Speaker: – Simulations Plus, Inc., Cognigen division
Career Center Speaker: – Simulations Plus
Career Center Speaker: – qPharmetra
Career Development
9:00 AM – 10:00 AM ET
The Skills You Need to be a Pharmaceutical ConsultantLocation:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – Certara
Career Center Moderator: – Certara
Career Center Speaker: – Certara
Career Center Speaker: – Simulations Plus, Inc., Cognigen division
Career Center Speaker: – Simulations Plus
Career Center Speaker: – qPharmetra
Career Development
Suzanne Minton, PhD – Certara ### 1650327###Career Center Moderator###Director, Content Strategy###Certara###Career Center Moderator: – Certara
### @@@ Mark Lovern, PhD – Certara ### 1650338###Career Center Moderator###Senior Vice President###Certara###Career Center Moderator: – Certara
### @@@ Dave Mitchell, PhD – Certara ### 1650339###Career Center Speaker###Senior Vice President###Certara###Career Center Speaker: – Certara
### @@@ Jill Fiedler-Kelly, MS, FISoP – Simulations Plus, Inc., Cognigen division ### 1777569###Career Center Speaker###President###Simulations Plus, Inc., Cognigen division###Career Center Speaker: – Simulations Plus, Inc., Cognigen division
### @@@ Alexander Berg, PharmD, PhD, FCP – Simulations Plus ### 1777570###Career Center Speaker###Vice President, Operations###Simulations Plus###Career Center Speaker: – Simulations Plus
### @@@ Ben Suttle, PhD – qPharmetra ### 1777571###Career Center Speaker###Principal Clinical Pharmacologist###qPharmetra###Career Center Speaker: – qPharmetra
### 9:00 AM – 10:00 AM ET
Understanding Formulation Challenges Early to Accelerate Timelines for FIH TrialsPartner Presentation Speaker: – Charles River Laboratories
Partner Presentation Speaker: – Charles River Laboratories
Preclinical Development
9:00 AM – 10:00 AM ET
Understanding Formulation Challenges Early to Accelerate Timelines for FIH TrialsLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Charles River Laboratories
Partner Presentation Speaker: – Charles River Laboratories
Preclinical Development
Presented By Charles River
Russell Scammell – Charles River Laboratories ### 1743113###Partner Presentation Speaker###Director Small Molecule Drug Discovery###Charles River Laboratories###Partner Presentation Speaker: – Charles River Laboratories
### @@@ Darren Matthews – Charles River Laboratories ### 1743114###Partner Presentation Speaker###Research Leader###Charles River Laboratories###Partner Presentation Speaker: – Charles River Laboratories
### 9:00 AM – 10:30 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Manufacturing & Analytical Characterization – Chemical
9:00 AM – 10:30 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Location:206 ABManufacturing & Analytical Characterization – Chemical
Sayantan Chattoraj, Ph.D. – GSK ### 828674###Moderator###Director & GSK Fellow, Drug Product Development###GSK###Moderator: – GSK
### 9:00 AM – 9:30 AM ET
Interplay between ML and Physics-Based Modeling Frameworks for Higher Fidelity and Deeper Structural InsightsLocation:206 ABManufacturing & Analytical Characterization – Chemical
Ahmad Sheikh, Ph.D – AbbVie ### 602532###Speaker###Senior Research Fellow###AbbVie###Speaker: – AbbVie
### 9:30 AM – 10:00 AM ET
Experimentally Validated Multiscale Modeling of Continuous Manufacturing of Complex InjectablesLocation:206 ABSpeaker: – University of Connecticut
Manufacturing & Analytical Characterization – Chemical
Bodhi Chaudhuri, Ph.D – University of Connecticut ### 603204###Speaker###Professor###University of Connecticut###Speaker: – University of Connecticut
### 10:00 AM – 10:30 AM ET
Accelerate Manufacturing Processes Development with Computational ChemistryLocation:206 ABSpeaker: – Hovione FarmaCiencia SA
Manufacturing & Analytical Characterization – Chemical
Luís M. Sobral, BS, MS – Hovione FarmaCiencia SA ### 1045417###Speaker###Fellow Scientist###Hovione FarmaCiencia SA###Speaker: – Hovione FarmaCiencia SA
### 9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)Clinical Pharmacology – Biomolecular
9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID DrugsLocation:152Clinical Pharmacology – Biomolecular
Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Moderator###Director, Clinical Pharmacology###Nimbus Therapeutics###Moderator: – Nimbus Therapeutics
### 9:00 AM – 9:30 AM ET
Role of Clinical Pharmacology in the Development of COVID-19 TherapeuticsLocation:152Speaker: – Regeneron Pharmaceuticals
Clinical Pharmacology – Biomolecular
Kenneth Turner, PhD – Regeneron Pharmaceuticals ### 1650345###Speaker###Sr Group Director, Clinical Pharmacology###Regeneron Pharmaceuticals###Speaker: – Regeneron Pharmaceuticals
### 9:30 AM – 10:00 AM ET
Role of Clinical Pharmacology in the Development of COVID-19 TherapeuticsLocation:152Clinical Pharmacology – Biomolecular
Bharat Damle, PhD – Pfizer ### 845568###Speaker###Executive Director###Pfizer###Speaker: – Pfizer
### 10:00 AM – 10:30 AM ET
Model Informed Drug Development of mRNA Vaccines: To COVID and BeyondLocation:152Speaker: – Moderna Therapeutics
Clinical Pharmacology – Biomolecular
Stephen A. Greene, PharmD – Moderna Therapeutics ### 1686435###Speaker###Associated Scientific Director, Clinical Pharmacology and Pharmacometrics###Moderna Therapeutics###Speaker: – Moderna Therapeutics
### 9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Moderator: – Gilead Sciences
Clinical Pharmacology – Chemical
9:00 AM – 10:30 AM ET
Symposium: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Location:151 ABModerator: – Gilead Sciences
Clinical Pharmacology – Chemical
Sandhya Girish, M.Pharm, PhD – Gilead Sciences ### 1718494###Moderator###Vice President, Head Clinical Pharmacology, Bioanalytical & Pharmacometrics###Gilead Sciences###Moderator: – Gilead Sciences
### 9:00 AM – 9:30 AM ET
Adapting a Controlled Infection Model Trial Interrupted by COVID19 PandemicLocation:151 ABGovernment Speaker: – NIH/NIAID
Clinical Pharmacology – Chemical
Richard Wu, MD – NIH/NIAID ### 1650355###Government Speaker###Staff Clinician###NIH/NIAID###Government Speaker: – NIH/NIAID
### 9:30 AM – 10:00 AM ET
Successful Development of siRNA, Vutrisiran, During COVID PandemicLocation:151 ABSpeaker: – Alnylam Pharmaceuticals
Clinical Pharmacology – Chemical
Gabriel Robbie, PhD – Alnylam Pharmaceuticals ### 1686438###Speaker###Senior Vice President###Alnylam Pharmaceuticals###Speaker: – Alnylam Pharmaceuticals
### 10:00 AM – 10:30 AM ET
Perspectives on the MIDD Aspects in Development of New Drugs During the COVID-19 PandemicLocation:151 ABGovernment Speaker: – FDA
Clinical Pharmacology – Chemical
Eliford Ngaimisi Kitabi, PhD – FDA ### 1686439###Government Speaker###Pharmacometrics reviewer###FDA###Government Speaker: – FDA
### 9:00 AM – 10:30 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (BM)Moderator: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
9:00 AM – 10:30 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (BM)Location:204 ABModerator: – Moderna Therapeutics
Formulation and Delivery – Biomolecular
Douglas Burdette, Ph.D. – Moderna Therapeutics ### 1718882###Moderator###Director, DMPK###Moderna Therapeutics###Moderator: – Moderna Therapeutics
### 9:00 AM – 9:30 AM ET
Addressing Global Health and Pandemic Threats by Microneedle Patch VaccinationLocation:204 ABSpeaker: – Georgia Institute of Technology
Formulation and Delivery – Biomolecular
Mark R. Prausnitz, PhD – Georgia Institute of Technology ### 605551###Speaker###Regents’ Professor###Georgia Institute of Technology###Speaker: – Georgia Institute of Technology
### 9:30 AM – 10:00 AM ET
Eliminating the Freeze: Vaccine Production is a Breeze with Thermostable FilmLocation:204 ABSpeaker: – University of Texas at Austin
Formulation and Delivery – Biomolecular
Maria A. Croyle, Ph.D. – University of Texas at Austin ### 1377356###Speaker###Glaxo Wellcome Professor of Pharmaceutics###University of Texas at Austin###Speaker: – University of Texas at Austin
### 10:00 AM – 10:30 AM ET
Thermal Stabilization of Biopharmaceuticals Using EnsilicationLocation:204 ABSpeaker: – University of Bath
Formulation and Delivery – Biomolecular
Asel Sartbaeva, PhD(Cantab) – University of Bath ### 1691767###Speaker###Associate Professor in Chemistry###University of Bath###Speaker: – University of Bath
### 9:00 AM – 11:00 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Manufacturing & Analytical Characterization – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Location:205 CManufacturing & Analytical Characterization – Biomolecular
Paul Logan Walsh, PhD – AbbVie ### 846991###Moderator###Director###AbbVie###Moderator: – AbbVie
### 9:00 AM – 9:30 AM ET
Microrheology of Biomolecular SolutionsLocation:205 CSpeaker: – University of Delaware
Manufacturing & Analytical Characterization – Biomolecular
Eric M. Furst, PhD – University of Delaware ### 1666001###Speaker###Professor###University of Delaware###Speaker: – University of Delaware
### 9:30 AM – 10:00 AM ET
Design of Biopharmaceutical Formulations Accelerated by Machine LearningLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Harini Narayanan, MSc, PhD – MIT ### 1773702###Speaker###Postdoctoral associate###MIT###Speaker: – MIT
### 10:00 AM – 10:30 AM ET
Frozen State Protein Aggregation and its Impact on Process DevelopmentLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Bharat Jagannathan, PhD – Amgen ### 1011706###Speaker###Principal Scientist###Amgen###Speaker: – Amgen
### 10:30 AM – 11:00 AM ET
2D-NMR for Higher Order Structure Assessment of Forced Degraded AntibodiesLocation:205 CManufacturing & Analytical Characterization – Biomolecular
Nithya Srinivasan, PhD – Amgen ### 1601015###Speaker###Sr Scientist###Amgen###Speaker: – Amgen
### 9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Location:253 BModerator: – BioAgilytix Labs
Bioanalytics – Biomolecular
Lynn Kamen, PhD – BioAgilytix Labs ### 1680382###Moderator###Scientific Officer###BioAgilytix Labs###Moderator: – BioAgilytix Labs
### 9:00 AM – 9:30 AM ET
Anti-AAV Pre-Existing Antibody Assays for Patient Enrollment: Format, Concordance and Clinical SensitivityLocation:253 BSpeaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Yanmei Lu, PhD – Sangamo Therapeutics ### 1650349###Speaker###VP of Biomarker and BioAnalytical Sciences###Sangamo Therapeutics###Speaker: – Sangamo Therapeutics
### 9:30 AM – 10:00 AM ET
Characterization of Early Immune Response to AAV Capsid; Case StudiesLocation:253 BBioanalytics – Biomolecular
John Kamerud, PhD – Pfizer ### 627136###Speaker###Director###Pfizer###Speaker: – Pfizer
### 10:00 AM – 10:30 AM ET
Characterizing Pre/Post Anti Capsid Immune-Response to Establish a Treatment-Emergent CriterionLocation:253 BBioanalytics – Biomolecular
Yanshan Dai, PhD – BMS ### 604744###Speaker###Senior Principal Scientist###BMS###Speaker: – BMS
### 10:30 AM – 11:00 AM ET
Designing a Cellular Immunogenicity Strategy for AAV Mediated ImmunityLocation:253 BBioanalytics – Biomolecular
Mitra Azadeh, PhD – Alkermes ### 1650351###Speaker###Director, Biomarker Operations, Translational Medicine & ESCD###Alkermes###Speaker: – Alkermes
### 9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Moderator: – Bristol-Myers Squibb
Bioanalytics – Chemical
9:00 AM – 11:00 AM ET
Symposium: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Location:253 AModerator: – Bristol-Myers Squibb
Bioanalytics – Chemical
Jian Chen, PhD – Bristol-Myers Squibb ### 1680383###Moderator###Senior Principal Scientist###Bristol-Myers Squibb###Moderator: – Bristol-Myers Squibb
### 9:00 AM – 9:30 AM ET
LC-MS Based Bioanalysis of Complex BiotherapeuticsLocation:253 ASpeaker: – Bristol Myers Squibb
Bioanalytics – Chemical
Srikanth Kotapati, PhD – Bristol Myers Squibb ### 1675272###Speaker###Senior Principal Scientist###Bristol Myers Squibb###Speaker: – Bristol Myers Squibb
### 9:30 AM – 10:00 AM ET
Keys to the Successful Development of Bioanalytical Method for OligonucleotidesLocation:253 ABioanalytics – Chemical
Jim Yamashita, PhD – WuXi AppTec ### 1650378###Speaker###Senior Director, Small Molecule Bioanalysis###WuXi AppTec###Speaker: – WuXi AppTec
### 10:00 AM – 10:30 AM ET
The Critical Role of Mobile Phase pH In the Performance of Oligonucleotide Ion-Pair Liquid Chromatography–Mass Spectrometry MethodsLocation:253 ASpeaker: – University of Georgia
Bioanalytics – Chemical
Gui Guimaraes – University of Georgia ### 1663781###Speaker###Graduate Student###University of Georgia###Speaker: – University of Georgia
### 10:30 AM – 11:00 AM ET
Reaching the Next Level of Sensitivity in Oligonucleotide Bioanalysis: A Hybridization-Based Method on Quanterix Simoa®Location:253 ASpeaker: – Labcorp Drug Development
Bioanalytics – Chemical
Bingbing Wang, PhD – Labcorp Drug Development ### 1663783###Speaker###Staff Scientist II###Labcorp Drug Development###Speaker: – Labcorp Drug Development
### 9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Moderator: – Merck & Co. Inc
Preclinical Development – Biomolecular
9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Location:254 AModerator: – Merck & Co. Inc
Preclinical Development – Biomolecular
Morgan B. Giles, PhD – Merck & Co. Inc ### 1759598###Moderator###Associate Principal Scientist###Merck & Co. Inc###Moderator: – Merck & Co. Inc
### 9:00 AM – 9:30 AM ET
An Unaddressed Scientific Need: Predicting Human Bioavailability of Subcutaneously Administered Fc-Fusion Proteins and Monoclonal AntibodiesLocation:254 ASpeaker: – Daiichi Sankyo Inc.
Preclinical Development – Biomolecular
Peng Zou, PhD – Daiichi Sankyo Inc. ### 844096###Speaker###Clinical Pharmacologist###Daiichi Sankyo Inc.###Speaker: – Daiichi Sankyo Inc.
### 9:30 AM – 10:00 AM ET
A Multifunctional Pre-Clinical Workstream to Advance ADC’s From Discovery to FIH DosingLocation:254 ASpeaker: – SUTRO Biopharma
Preclinical Development – Biomolecular
Werner Rubas, PhD – SUTRO Biopharma ### 856966###Speaker###VIP Preclinical Development###SUTRO Biopharma###Speaker: – SUTRO Biopharma
### 10:00 AM – 10:30 AM ET
Understanding Protein Excipient Compatibility- Smart Decision for Speed to ClinicLocation:254 ASpeaker: – Boehringer Ingelheim Pharmaceutical Inc
Preclinical Development – Biomolecular
Seema Thakral, PhD – Boehringer Ingelheim Pharmaceutical Inc ### 1045161###Speaker###Head, Preclinical Formulations###Boehringer Ingelheim Pharmaceutical Inc###Speaker: – Boehringer Ingelheim Pharmaceutical Inc
### 10:30 AM – 11:00 AM ET
Challenges in Development of Cell and Gene Therapies GloballyLocation:254 ASpeaker: – SymphonyTech Biologucs
Preclinical Development – Biomolecular
Narendra Chirmule, Dr. – SymphonyTech Biologucs ### 516216###Speaker###CEO###SymphonyTech Biologucs###Speaker: – SymphonyTech Biologucs
### 9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Moderator: – University of Toronto
Preclinical Development – Chemical
9:00 AM – 11:00 AM ET
Symposium: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Location:253 CModerator: – University of Toronto
Preclinical Development – Chemical
Sarah Cash – University of Toronto ### 1447132###Moderator###PhD Candidate###University of Toronto###Moderator: – University of Toronto
### 9:00 AM – 9:30 AM ET
Single Formulation for Preclinical, F-I-H and Commercial Dosage FormLocation:253 CSpeaker: – Nano PharmaSolutions
Preclinical Development – Chemical
Kay Olmstead, PhD – Nano PharmaSolutions ### 1650361###Speaker###CEO###Nano PharmaSolutions###Speaker: – Nano PharmaSolutions
### 9:30 AM – 10:00 AM ET
In vitro Models of Subcutaneous DeliveryLocation:253 CSpeaker: – Massachusetts Institute of Technology
Preclinical Development – Chemical
Maria Proestaki, PhD – Massachusetts Institute of Technology ### 1778458###Speaker###Postdoctoral Associate###Massachusetts Institute of Technology ###Speaker: – Massachusetts Institute of Technology
### 10:00 AM – 10:30 AM ET
Model Informed Drug Development: A Key Metric to Expedite Compound Progression in Drug DiscoveryLocation:253 CSpeaker: – Quotient Sciences, UK
Preclinical Development – Chemical
Shriram M. Pathak, PhD – Quotient Sciences, UK ### 847359###Speaker###Senior Research Fellow, Drug Development Consulting###Quotient Sciences, UK###Speaker: – Quotient Sciences, UK
### 10:30 AM – 11:00 AM ET
New Tools to Bridge Chemistry and Biology SilosLocation:253 CPreclinical Development – Chemical
Keith Hornberger, PhD – Arvinas, Inc. ### 1686551###Speaker###Senior Director, Medicinal Chemistry###Arvinas, Inc.###Speaker: – Arvinas, Inc.
### 9:00 AM – 11:00 AM ET
Symposium: Oncotargets: Challenges & OpportunitiesModerator: – Northeastern University
Discovery and Basic Research
9:00 AM – 11:00 AM ET
Symposium: Oncotargets: Challenges & OpportunitiesLocation:255Moderator: – Northeastern University
Discovery and Basic Research
Stephen Hatfield, PhD – Northeastern University ### 1691763###Moderator###Assistant Professor###Northeastern University ###Moderator: – Northeastern University
### 9:00 AM – 9:30 AM ET
New Therapeutic Approaches in Acute Myeloid LeukemiaLocation:255Speaker: – University of Southern California
Discovery and Basic Research
Houda Alachkar, PharmD, PhD – University of Southern California ### 1699108###Speaker###Associate Professor ###University of Southern California###Speaker: – University of Southern California
### 9:30 AM – 10:00 AM ET
Novel Thyrointegrin αvβ3 Antagonist in the Effective Treatment of Glioblastoma Multiforme and Other CancersLocation:255Speaker: – PRI at ACPHS & NanoPharmaceuticals LLC
Discovery and Basic Research
Shaker A. Mousa, PhD, MBA, – PRI at ACPHS & NanoPharmaceuticals LLC ### 1676845###Speaker###Prof., Executive VP of R&D and Founder of NanoPharmaceuticals LLC###PRI at ACPHS & NanoPharmaceuticals LLC###Speaker: – PRI at ACPHS & NanoPharmaceuticals LLC
### 10:00 AM – 10:30 AM ET
Systems Pharmacology in Developing Targeted and Long-Acting (Long-Lasting) Drug Combinations for Metastatic CancersLocation:255Speaker: – Center for WE-REACH
Discovery and Basic Research
Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH ### 1046065###Speaker###Executive Director and Professor###Center for WE-REACH###Speaker: – Center for WE-REACH
### 10:30 AM – 11:00 AM ET
High-Throughput 3D Bio-Printed Tumor Microenvironment Platform for Mimicking Lung CancerLocation:255Speaker: – University of Florida
Discovery and Basic Research
Nina Erwin – University of Florida ### 1755669###Speaker###Graduate Student###University of Florida###Speaker: – University of Florida
### 9:00 AM – 11:00 AM ET
Symposium: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesModerator: – University of North Carolina
Discovery and Basic Research
9:00 AM – 11:00 AM ET
Symposium: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesLocation:254 BModerator: – University of North Carolina
Discovery and Basic Research
Alexander Tropsha, PhD – University of North Carolina ### 1695022###Moderator###KH Lee Distinguished Professor###University of North Carolina ###Moderator: – University of North Carolina
### 9:00 AM – 9:30 AM ET
Mass Spectrometry Imaging in Drug Discovery and Better Therapeutic DesignLocation:254 BSpeaker: – Columbia University
Discovery and Basic Research
Presha Rajbhandari, PhD – Columbia University ### 1650384###Speaker###Associate Research Scientist, Department of Biological Sciences###Columbia University###Speaker: – Columbia University
### 9:30 AM – 10:00 AM ET
Bioinformatic Driven Translation of Precision Genomic TherapyLocation:254 BSpeaker: – University of Florida
Discovery and Basic Research
Kiley Graim, PhD – University of Florida ### 1378144###Speaker###Assistant Professor###University of Florida###Speaker: – University of Florida
### 10:00 AM – 10:30 AM ET
Accelerating Computational Drug Discovery with Machine Learning and AILocation:254 BSpeaker: – Carnegie Mellon University
Discovery and Basic Research
Olexandr Isayev, PhD (he/him/his) – Carnegie Mellon University ### 1688940###Speaker###Professor###Carnegie Mellon University###Speaker: – Carnegie Mellon University
### he/him/his10:30 AM – 11:00 AM ET
What's Needed to Fully Enable Artificial Intelligence (AI) for Drug Discovery?Location:254 BDiscovery and Basic Research
Han Lim, PhD – DeepCure ### 1688941###Speaker###Chief Business Officer###DeepCure###Speaker: – DeepCure
### 9:00 AM – 11:00 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (CE)Moderator: – University of Florida
Formulation and Delivery – Chemical
9:00 AM – 11:00 AM ET
Symposium: Recent Development in Prophylactic Therapies and Vaccines (CE)Location:205 ABModerator: – University of Florida
Formulation and Delivery – Chemical
Rodrigo Cristofoletti, PhD – University of Florida ### 1650917###Moderator###Assistant Professor ###University of Florida###Moderator: – University of Florida
### 9:00 AM – 9:30 AM ET
Maturing Role of Systems Pharmacology, Long-Acting and Targeted Drug-Combination Technologies in Making Health Impact in Long-Acting TherapeuticsLocation:205 ABSpeaker: – Center for WE-REACH
Formulation and Delivery – Chemical
Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH ### 1046065###Speaker###Executive Director and Professor###Center for WE-REACH###Speaker: – Center for WE-REACH
### 9:30 AM – 10:00 AM ET
Long-Acting Drug Delivery Systems for ContraceptionLocation:205 ABFormulation and Delivery – Chemical
Jennifer Ayres, PhD – FHI 360 ### 1730308###Speaker###Pharmaceutical Development Manager###FHI 360###Speaker: – FHI 360
### 10:00 AM – 10:30 AM ET
Developments in Prophylactic Treatments for MalariaLocation:205 ABSpeaker: – Medicines for Malaria Venture (MMV)
Formulation and Delivery – Chemical
Hanu Ramachandruni, PhD – Medicines for Malaria Venture (MMV) ### 1698804###Speaker###Senior Director, Pharmaceutical Development###Medicines for Malaria Venture (MMV)###Speaker: – Medicines for Malaria Venture (MMV)
### 10:30 AM – 11:00 AM ET
Optimizing HIV Postnatal Prophylaxis: Ongoing Collaborative EffortsLocation:205 ABSpeaker: – World Health Organization
Formulation and Delivery – Chemical
Martina Penazzato, MD, MSc, PhD (she/her/hers) – World Health Organization ### 1795256###Speaker###GAP-f lead###World Health Organization###Speaker: – World Health Organization
### she/her/hers9:30 AM – 10:00 AM ET
Coffee Break in the Solution Center
9:30 AM – 10:00 AM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
9:30 AM – 10:30 AM ET
Evaluation of Advanced Container Surface Technologies for Sensitive Drugs ProductsFormulation and Delivery
9:30 AM – 10:30 AM ET
Evaluation of Advanced Container Surface Technologies for Sensitive Drug ProductsLocation:360 Stage #4, Exhibit Hall A&BFormulation and Delivery
Rob Swanda, PhD – Becton Dickinson ### 1764085###Partner Presentation Speaker###R&D Innovation Leader###Becton Dickinson###Partner Presentation Speaker: – Becton Dickinson
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Advances in Co-Processed APIs, Transformative Technologies to Optimize Physicochemical PropertiesSpotlight Speaker: – Merck & Co., Inc.
Moderator: – Organon
Manufacturing & Analytical Characterization
9:30 AM – 10:30 AM ET
Speaker Spotlight: Advances in Co-Processed APIs, Transformative Technologies to Optimize Physicochemical PropertiesLocation:Spotlight Stage 3, Exhibit Hall A&BSpotlight Speaker: – Merck & Co., Inc.
Moderator: – Organon
Manufacturing & Analytical Characterization
Luke Schenck – Merck & Co., Inc. ### 604981###Spotlight Speaker###Principal Scientist###Merck & Co., Inc.###Spotlight Speaker: – Merck & Co., Inc.
### @@@ Maria Cruanes, PhD Chemistry (she/her/hers) – Organon ### 1680406###Moderator###Director Analytical Chemistry ###Organon###Moderator: – Organon
### she/her/hers9:30 AM – 10:30 AM ET
Speaker Spotlight: The Intersection of Hepatic Transporters and Drug-Induced Liver Injury: Preclinical Tools to Advance Mechanistic Understanding and Precision MedicineSpotlight Speaker: – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
Moderator: – University of North Carolina - Chapel Hill
Preclinical Development
9:30 AM – 10:30 AM ET
Speaker Spotlight: The Intersection of Hepatic Transporters and Drug-Induced Liver Injury: Preclinical Tools to Advance Mechanistic Understanding and Precision MedicineLocation:Spotlight Stage 1, Exhibit Hall A&BSpotlight Speaker: – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
Moderator: – University of North Carolina - Chapel Hill
Preclinical Development
Kim L.R Brouwer, PharmD, PhD – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
### 567627###Spotlight Speaker###Associate Dean for Research and Graduate Education
William R. Kenan, Jr., Distinguished Professor###UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
###Spotlight Speaker: – UNC Eshelman School of Pharmacy
The University of North Carolina at Chapel Hill
### @@@ Mattie Hartauer – University of North Carolina - Chapel Hill ### 1678282###Moderator###Graduate Student###University of North Carolina - Chapel Hill###Moderator: – University of North Carolina - Chapel Hill
### 9:30 AM – 10:30 AM ET
Speaker Spotlight: Translational Biomarkers for Rare Disease Gene Therapies, Limitations and OpportunitiesSpotlight Speaker: – Pfizer
Moderator: – BioAgilytix
Clinical Pharmacology – Biomolecular
9:30 AM – 10:30 AM ET
Speaker Spotlight: Translational Biomarkers for Rare Disease Gene Therapies, Limitations and OpportunitiesLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Pfizer
Moderator: – BioAgilytix
Clinical Pharmacology – Biomolecular
Mohamed Hassanein, PhD – Pfizer ### 1328461###Spotlight Speaker###Associate Director###Pfizer###Spotlight Speaker: – Pfizer
### @@@ Shazia Baig, PhD (she/her/hers) – BioAgilytix ### 1601056###Moderator###Scientist II###BioAgilytix###Moderator: – BioAgilytix
### she/her/hers9:30 AM – 10:30 AM ET
Successful Collaboration Delivering Impactful Solutions to Novel Challenges in PharmaPartner Presentation Speaker: – SGS Health Science
Partner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
9:30 AM – 10:30 AM ET
Successful Collaboration Delivering Impactful Solutions to Novel Challenges in PharmaLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – SGS Health Science
Partner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
Paulina Pinedo-Gonzalez, PhD – SGS Health Science ### 1743111###Partner Presentation Speaker###Chemist###SGS Health Science###Partner Presentation Speaker: – SGS Health Science
### @@@ Simon Szwandt, PhD (he/him/his) – Thermo Fisher Scientific ### 1804041###Partner Presentation Speaker###Senior Field Scientist###Thermo Fisher Scientific###Partner Presentation Speaker: – Thermo Fisher Scientific
### he/him/his10:00 AM – 11:00 AM ET
Hot Topic: Careers in Biopharmaceutics Related Fields: A Career Development Panel DiscussionHot Topic Moderator: – Eli Lilly and Company
Hot Topic Speaker: – Eli Lilly and Company
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – University of Bath
Government Speaker: – US Food and Drug Administration, Invited
Formulation and Delivery – Chemical
10:00 AM – 11:00 AM ET
Hot Topic: Careers in Biopharmaceutics Related Fields: A Career Development Panel DiscussionLocation:153 BCHot Topic Moderator: – Eli Lilly and Company
Hot Topic Speaker: – Eli Lilly and Company
Hot Topic Speaker: – Merck & Co., Inc.
Hot Topic Speaker: – University of Bath
Government Speaker: – US Food and Drug Administration, Invited
Formulation and Delivery – Chemical
Siddhi S. Hate, PhD – Eli Lilly and Company ### 1650342###Hot Topic Moderator###Advisor###Eli Lilly and Company###Hot Topic Moderator: – Eli Lilly and Company
### @@@ David C. Sperry, PhD – Eli Lilly and Company ### 1011708###Hot Topic Speaker###Executive Director###Eli Lilly and Company###Hot Topic Speaker: – Eli Lilly and Company
### @@@ Andre Hermans, PhD – Merck & Co., Inc. ### 624038###Hot Topic Speaker###Director###Merck & Co., Inc.###Hot Topic Speaker: – Merck & Co., Inc.
### @@@ Nikoletta Fotaki, PhD – University of Bath ### 847632###Hot Topic Speaker###Reader in (Bio)Pharmaceutics###University of Bath###Hot Topic Speaker: – University of Bath
### @@@ Paul Seo, PhD – US Food and Drug Administration, Invited ### 603903###Government Speaker###Policy Lead###US Food and Drug Administration, Invited###Government Speaker: – US Food and Drug Administration, Invited
### 10:00 AM – 11:00 AM ET
Meet The Employers: Hosted by Certara
10:00 AM – 11:00 AM ET
Meet The Employer: Hosted by CertaraLocation:Career Development Center, Exhibit Hall A&BCareer Development
10:30 AM – 11:30 AM ET
Nose to Brain Delivery: possibility or a pipedream?Partner Presentation Speaker: – Lovelace Biomedical Research Institute
Partner Presentation Speaker: – Aptar Pharma
Preclinical Development
10:30 AM – 11:30 AM ET
Nose to Brain Delivery: possibility or a pipedream?Location:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Lovelace Biomedical Research Institute
Partner Presentation Speaker: – Aptar Pharma
Preclinical Development
Philip J. Kuehl, PhD – Lovelace Biomedical Research Institute ### 603512###Partner Presentation Speaker###Senior Scientist###Lovelace Biomedical Research Institute###Partner Presentation Speaker: – Lovelace Biomedical Research Institute
### @@@ Julie D. Suman, PhD – Aptar Pharma ### 848555###Partner Presentation Speaker###Vice President, Scientific Affairs###Aptar Pharma###Partner Presentation Speaker: – Aptar Pharma
### 10:30 AM – 11:30 AM ET
Special Poster Collection - 2022 PharmSci 360 Best Posters
10:30 AM – 11:30 AM ET
Special Poster Collection - 2022 PharmSci 360 Best PostersLocation:Poster Forum #10, Exhibit Hall A&BPoster Collection Host: – Trinity College Dublin
Carsten Ehrhardt, Ph.D. – Trinity College Dublin ### 1536972###Poster Collection Host###Professor in Pharmaceutics and Biopharmaceutics###Trinity College Dublin###Poster Collection Host: – Trinity College Dublin
### 10:30 AM – 11:30 AM ET
Strategically Design Your Path to Career SuccessCareer Center Speaker: – Merck & Co.
Career Center Speaker: – Pharmawyze
Career Center Speaker: – BMS
Career Center Speaker: – Bristol Myers Squibb
Career Center Moderator: – Merck & Co., Inc.
Career Development
10:30 AM – 11:30 AM ET
Strategically Design Your Path to Career SuccessLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Merck & Co.
Career Center Speaker: – Pharmawyze
Career Center Speaker: – BMS
Career Center Speaker: – Bristol Myers Squibb
Career Center Moderator: – Merck & Co., Inc.
Career Development
Nicole Buist, PhD – Merck & Co. ### 1529534###Career Center Speaker###Senior Director###Merck & Co.###Career Center Speaker: – Merck & Co.
### @@@ Ronald L. Smith, PhD, FAAPS – Pharmawyze ### 1529533###Career Center Speaker###Principal###Pharmawyze###Career Center Speaker: – Pharmawyze
### @@@ Anthony Leone, PhD – BMS ### 1650350###Career Center Speaker###Executive Director-Head Analytical Development and Attribute Sciences###BMS###Career Center Speaker: – BMS
### @@@ Tapan Das, PhD, FAAPS – Bristol Myers Squibb ### 567541###Career Center Speaker###Senior Director###Bristol Myers Squibb###Career Center Speaker: – Bristol Myers Squibb
### @@@ Jing Ling, PhD – Merck & Co., Inc. ### 1650352###Career Center Moderator###Associate Principal Scientist###Merck & Co., Inc.###Career Center Moderator: – Merck & Co., Inc.
### 11:00 AM – 12:00 PM ET
A toxicologist’s viewpoint on the safe manufacturing of oncology drugsPartner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
11:00 AM – 12:00 PM ET
A toxicologist’s viewpoint on the safe manufacturing of oncology drugsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Thermo Fisher Scientific
Manufacturing & Analytical Characterization
Joe Galati, PhD – Thermo Fisher Scientific ### 1743097###Partner Presentation Speaker###Sr. Director, Global Toxicology Services###Thermo Fisher Scientific###Partner Presentation Speaker: – Thermo Fisher Scientific
### 11:00 AM – 12:00 PM ET
Patient Centric Sampling to Enable Decentralization of Clinical TrialsPartner Presentation Speaker: – Labcorp
Bioanalytics
11:00 AM – 12:00 PM ET
Patient Centric Sampling to Enable Decentralization of Clinical TrialsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Labcorp
Bioanalytics
Stephanie Cape, PhD (she/her/hers) – Labcorp ### 627114###Partner Presentation Speaker###Head of R&D - Scientific Affairs, Clinical Trials Testing Solutions###Labcorp###Partner Presentation Speaker: – Labcorp
### she/her/hers11:00 AM – 1:30 PM ET
Dedicated Solution Center Hours
11:00 AM – 1:30 PM ET
Dedicated Solution Center HoursLocation:Exhibit Hall A&B
11:15 AM – 12:00 PM ET
Characterization of Dextran/Heparin via GPC/SEC Advanced detection with 21-CFR11-Compliant softwareChalk Talk Presenter: – PSS USA Inc
Chalk Talk Presenter: – Agilent Technologies
Manufacturing & Analytical Characterization
11:15 AM – 12:00 PM ET
Characterization of Dextran/Heparin via GPC/SEC Advanced detection with 21-CFR11-Compliant softwareLocation:Spotlight Stage 3, Exhibit Hall A&BChalk Talk Presenter: – PSS USA Inc
Chalk Talk Presenter: – Agilent Technologies
Manufacturing & Analytical Characterization
Derek Lohmann, PhD – PSS USA Inc ### 1778369###Chalk Talk Presenter###VP Sales & Business Development###PSS USA Inc###Chalk Talk Presenter: – PSS USA Inc
### @@@ Lorena Lopez, BSc / MBA – Agilent Technologies ### 1767416###Chalk Talk Presenter###LC Applications Scientist###Agilent Technologies###Chalk Talk Presenter: – Agilent Technologies
### 11:15 AM – 12:00 PM ET
Nitrosamine Risk Management and Analytical TestingChalk Talk Presenter: – Cambrex
Manufacturing & Analytical Characterization
11:15 AM – 12:00 PM ET
Nitrosamine Risk Management and Analytical TestingLocation:Spotlight Stage 2, Exhibit Hall A&BChalk Talk Presenter: – Cambrex
Manufacturing & Analytical Characterization
Caddy Hobbs, PhD (she/her/hers) – Cambrex ### 1807703###Chalk Talk Presenter###Associate Director###Cambrex###Chalk Talk Presenter: – Cambrex
### she/her/hers11:15 AM – 12:00 PM ET
Supporting R&D with Nondilutive Federal FundingChalk Talk Presenter: – EverGlade Consulting
Discovery and Basic Research
11:15 AM – 12:00 PM ET
Supporting R&D with Nondilutive Federal FundingLocation:Spotlight Stage 1, Exhibit Hall A&BChalk Talk Presenter: – EverGlade Consulting
Discovery and Basic Research
Presented By EverGlade Everglade
Stephen Morris, PhD – EverGlade Consulting ### 1778368###Chalk Talk Presenter###Managing Director###EverGlade Consulting###Chalk Talk Presenter: – EverGlade Consulting
### 11:45 AM – 1:30 PM ET
AAPS Student Meet Up
11:45 AM – 1:30 PM ET
AAPS Student Meet UpLocation:North Lobby
12:00 PM – 1:00 PM ET
Developing Sustainable Environments for DE&I Across a Global WorkplaceCareer Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Oral Formulation Sciences, Merck & Co., Inc.
Career Development
12:00 PM – 1:00 PM ET
Developing Sustainable Environments for DE&I Across a Global WorkplaceLocation:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Merck & Co., Inc.
Career Center Speaker: – Oral Formulation Sciences, Merck & Co., Inc.
Career Development
Stephanie Barrett, PhD – Merck & Co., Inc. ### 466169###Career Center Speaker###Director, Sterile & Specialty Products###Merck & Co., Inc.###Career Center Speaker: – Merck & Co., Inc.
### @@@ Neil Strotman, PhD – Merck & Co., Inc. ### 1650368###Career Center Speaker###Director, Formulations Science###Merck & Co., Inc.###Career Center Speaker: – Merck & Co., Inc.
### @@@ Devin Swiner, PhD (she/her/hers) – Merck & Co., Inc. ### 1767219###Career Center Speaker###Senior Scientist###Merck & Co., Inc.###Career Center Speaker: – Merck & Co., Inc.
### she/her/hers @@@ Alita Miller, MS – Oral Formulation Sciences, Merck & Co., Inc. ### 1808843###Career Center Speaker###Scientist###Oral Formulation Sciences, Merck & Co., Inc.###Career Center Speaker: – Oral Formulation Sciences, Merck & Co., Inc.
### 12:00 PM – 1:00 PM ET
Mass spectrometry Based Characterization of OligonucleotidesPartner Presentation Speaker: – Agilent Technologies
Manufacturing & Analytical Characterization
12:00 PM – 1:00 PM ET
Mass spectrometry Based Characterization of OligonucleotidesLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Agilent Technologies
Manufacturing & Analytical Characterization
Michael Knierman – Agilent Technologies ### 1743103###Partner Presentation Speaker###Biopharma Workflow Manager###Agilent Technologies###Partner Presentation Speaker: – Agilent Technologies
### 12:00 PM – 2:00 PM ET
The AAPS Journal Editor Strategy Meeting (by invitation only)
12:00 PM – 2:00 PM ET
The AAPS Journal Editor Strategy Meeting (by invitation only)
Location:Executive Boardroom, Westin Boston Seaport District Hotel
12:30 PM – 1:15 PM ET
AAPS Regulatory Sciences Community Membership Meeting Community Leader: – Tolmar, Inc.
12:30 PM – 1:15 PM ET
AAPS Regulatory Sciences Community Membership Meeting Location:Spotlight Stage 2, Exhibit Hall A&BCommunity Leader: – Tolmar, Inc.
Raja B. Velagapudi, PhD – Tolmar, Inc. ### 567542###Community Leader###Sr. Dir., Clinical Development###Tolmar, Inc.###Community Leader: – Tolmar, Inc.
### 12:30 PM – 1:15 PM ET
NextGen – CMC. Innovation, Digitization, Contextualization, and Analytics of Manufacturing DataChalk Talk Presenter: – Mareana, Inc.
Manufacturing & Analytical Characterization
12:30 PM – 1:15 PM ET
NextGen – CMC. Innovation, Digitization, Contextualization, and Analytics of Manufacturing DataLocation:Spotlight Stage 1, Exhibit Hall A&BChalk Talk Presenter: – Mareana, Inc.
Manufacturing & Analytical Characterization
Vishal Prasad – Mareana, Inc. ### 1804060###Chalk Talk Presenter###Founder and CPO###Mareana, Inc.###Chalk Talk Presenter: – Mareana, Inc.
### 12:30 PM – 1:15 PM ET
Sprinkle Formulations: A Convenient Dosing Platform for Special PopulationsChalk Talk Presenter: – Adare Pharma Solutions
Formulation and Delivery
12:30 PM – 1:15 PM ET
Sprinkle Formulations: A Convenient Dosing Platform for Special PopulationsLocation:Spotlight Stage 3, Exhibit Hall A&BChalk Talk Presenter: – Adare Pharma Solutions
Formulation and Delivery
Srinivasan Shanmugam, PhD – Adare Pharma Solutions ### 1473182###Chalk Talk Presenter###Senior Director, Pharmaceutical Sciences, Business Support, and New Technologies###Adare Pharma Solutions###Chalk Talk Presenter: – Adare Pharma Solutions
### 12:30 PM – 1:30 PM ET
FDA Modernization ACT: What's the Future of Current Test SystemsPartner Presentation Speaker: – Lovelace Biomedical
Partner Presentation Speaker: – LifeNet Health
Partner Presentation Speaker: – Emulate
Preclinical Development
12:30 PM – 1:30 PM ET
FDA Modernization ACT: What's the Future of Current Test SystemsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Lovelace Biomedical
Partner Presentation Speaker: – LifeNet Health
Partner Presentation Speaker: – Emulate
Preclinical Development
Jake McDonald, PhD – Lovelace Biomedical ### 1044871###Partner Presentation Speaker###VP, Applied Sciences###Lovelace Biomedical###Partner Presentation Speaker: – Lovelace Biomedical
### @@@ Jim McKim, PhD, DABT – LifeNet Health ### 1764086###Partner Presentation Speaker###Executive Director###LifeNet Health###Partner Presentation Speaker: – LifeNet Health
### @@@ Lorna Ewart, PhD – Emulate ### 1764087###Partner Presentation Speaker###Chief Scientific Officer###Emulate###Partner Presentation Speaker: – Emulate
### 12:30 PM – 1:30 PM ET
Mutagenic Impurities Analysis: Response Factor Variation on Quantitative AccuracyPartner Presentation Speaker: – Jordi Labs
Manufacturing & Analytical Characterization
12:30 PM – 1:30 PM ET
Mutagenic Impurities Analysis: Response Factor Variation on Quantitative AccuracyLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Jordi Labs
Manufacturing & Analytical Characterization
Adam Eason, MSc (he/him/his) – Jordi Labs ### 1807477###Partner Presentation Speaker###Senior Study Director###Jordi Labs###Partner Presentation Speaker: – Jordi Labs
### he/him/his12:30 PM – 1:30 PM ET
Special Poster Collection
12:30 PM – 1:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Janssen R&D, LLC
Poster Collection Host: – Johnson and Johnson
Gopi Shankar, AAPS Fellow – Janssen R&D, LLC ### 572031###Poster Collection Host###Senior Director###Janssen R&D, LLC###Poster Collection Host: – Janssen R&D, LLC
### @@@ Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Poster Collection Host###Scientific Director###Johnson and Johnson ###Poster Collection Host: – Johnson and Johnson
### 1:30 PM – 2:30 PM ET
Equip yourself for independence!Career Center Speaker: – Johnson and Johnson
Career Center Moderator: – Neurocrine Biosciences
Career Center Speaker: – Nimbus Therapeutics
Career Development
1:30 PM – 2:30 PM ET
Equip Yourself for Independence!Location:360 Stage #3, Exhibit Hall A&BCareer Center Speaker: – Johnson and Johnson
Career Center Moderator: – Neurocrine Biosciences
Career Center Speaker: – Nimbus Therapeutics
Career Development
Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Career Center Speaker###Scientific Director###Johnson and Johnson ###Career Center Speaker: – Johnson and Johnson
### @@@ Pankajini Mallick, PhD – Neurocrine Biosciences ### 1329420###Career Center Moderator###Principal Scientist, Preclinical Pharmacokinetics | DMPK###Neurocrine Biosciences###Career Center Moderator: – Neurocrine Biosciences
### @@@ Nimita Dave, PhD – Nimbus Therapeutics ### 1650370###Career Center Speaker###Director, Clinical Pharmacology###Nimbus Therapeutics###Career Center Speaker: – Nimbus Therapeutics
### 1:30 PM – 2:30 PM ET
Keynote: COVID-19: A Disruptive Force Transforming Clinical Pharmacology and Medicines DevelopmentKeynote Speaker: – Pfizer
Moderator: – Pfizer Inc.
Clinical Pharmacology
1:30 PM – 2:30 PM ET
Keynote: COVID-19: A Disruptive Force Transforming Clinical Pharmacology and Medicines DevelopmentLocation:151 ABKeynote Speaker: – Pfizer
Moderator: – Pfizer Inc.
Clinical Pharmacology
Brian Corrigan, PhD – Pfizer ### 1595388###Keynote Speaker###Global Head, Clinical Pharmacology###Pfizer###Keynote Speaker: – Pfizer
### @@@ Vaishali Sahasrabudhe, PhD (she/her/hers) – Pfizer Inc. ### 1045004###Moderator###Clinical Pharmacology Therapeutic Area Head for Internal Medicine###Pfizer Inc.###Moderator: – Pfizer Inc.
### she/her/hers1:30 PM – 2:30 PM ET
Keynote: Designing Function-Selective Kinase Inhibitors: Taking an Idea to Clinical Trials Keynote Speaker: – University of Maryland School of Pharmacy
Moderator: – University of North Carolina
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Designing Function-Selective Kinase Inhibitors: Taking an Idea to Clinical Trials Location:254 BKeynote Speaker: – University of Maryland School of Pharmacy
Moderator: – University of North Carolina
Discovery and Basic Research
Paul Shapiro, PhD – University of Maryland School of Pharmacy ### 1606391###Keynote Speaker###Professor###University of Maryland School of Pharmacy###Keynote Speaker: – University of Maryland School of Pharmacy
### @@@ Alexander Tropsha, PhD – University of North Carolina ### 1695022###Moderator###KH Lee Distinguished Professor###University of North Carolina ###Moderator: – University of North Carolina
### 1:30 PM – 2:30 PM ET
Keynote: Development of mRNA based Covid Vaccine Keynote Speaker: – Pfizer Inc.
Moderator: – Husson University
Formulation and Delivery – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Development of mRNA Based Covid Vaccine Location:204 ABKeynote Speaker: – Pfizer Inc.
Moderator: – Husson University
Formulation and Delivery – Biomolecular
Nicholas Warne, PhD – Pfizer Inc. ### 994019###Keynote Speaker###Vice President###Pfizer Inc.###Keynote Speaker: – Pfizer Inc.
### @@@ Shuhua Bai, PhD – Husson University ### 1378203###Moderator###Professor###Husson University###Moderator: – Husson University
### 1:30 PM – 2:30 PM ET
Keynote: Dragons and Invisible Helicopters: Evolution of Analytical TechnologiesKeynote Speaker: – Merck
Moderator: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Dragons and Invisible Helicopters: Evolution of Analytical TechnologiesLocation:205 CKeynote Speaker: – Merck
Moderator: – AbbVie
Manufacturing & Analytical Characterization – Biomolecular
Ian Mangion, PhD – Merck ### 856408###Keynote Speaker###Executive Director###Merck###Keynote Speaker: – Merck
### @@@ Paul Logan Walsh, PhD – AbbVie ### 846991###Moderator###Director###AbbVie###Moderator: – AbbVie
### 1:30 PM – 2:30 PM ET
Keynote: Integrated Risk/Benefit Assessment to Inform Decision Making in Drug Discovery
Preclinical Development – Chemical
1:30 PM – 2:30 PM ET
Keynote: Integrated Risk/Benefit Assessment to Inform Decision Making in Drug Discovery Location:253 CPreclinical Development – Chemical
Thierry Lavé, PhD (he/him/his) – Hoffman-la Roche Inc ### 1417631###Keynote Speaker###Head R&D Academy and Faculty###Hoffman-la Roche Inc###Keynote Speaker: – Hoffman-la Roche Inc
### he/him/his @@@ Christine Bowman, PhD – Genentech ### 1372299###Moderator###Senior Scientist###Genentech###Moderator: – Genentech
### 1:30 PM – 2:30 PM ET
Keynote: Keynote: A Vision for Accelerating Oral Solid Dosage Drug Product Development Using Material Science and SimulationManufacturing & Analytical Characterization – Chemical
1:30 PM – 2:30 PM ET
Keynote: A Vision for Accelerating Oral Solid Dosage Drug Product Development Using Material Science and SimulationLocation:206 ABManufacturing & Analytical Characterization – Chemical
Robert Yule – Sanofi ### 1595391###Keynote Speaker###Head of Operations, Data and Modeling###Sanofi###Keynote Speaker: – Sanofi
### @@@ Sayantan Chattoraj, Ph.D. – GSK ### 828674###Moderator###Director & GSK Fellow, Drug Product Development###GSK###Moderator: – GSK
### 1:30 PM – 2:30 PM ET
Keynote: Oligonucleotides, Where We Started, Where We Stand, and Where We Would Like GoKeynote Speaker: – Pyxant Labs Inc.
Moderator: – Virginia Commonwealth University
Bioanalytics – Chemical
1:30 PM – 2:30 PM ET
Keynote: Oligonucleotides, Where We Started, Where We Stand, and Where We Would Like GoLocation:253 AKeynote Speaker: – Pyxant Labs Inc.
Moderator: – Virginia Commonwealth University
Bioanalytics – Chemical
Troy Voelker, PhD – Pyxant Labs Inc. ### 1447215###Keynote Speaker###Director of Laboratory Operations###Pyxant Labs Inc.###Keynote Speaker: – Pyxant Labs Inc.
### @@@ Matthew S. Halquist, PhD – Virginia Commonwealth University ### 1447055###Moderator###Associate Professor and Laboratory Director###Virginia Commonwealth University###Moderator: – Virginia Commonwealth University
### 1:30 PM – 2:30 PM ET
Keynote: Opportunities and Challenges in Translating Novel Discoveries into Biologic Drugs in R&D: From Oncology to NeurologyKeynote Speaker: – Alector
Moderator: – Repare Therapeutics
Preclinical Development – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: Opportunities and Challenges in Translating Novel Discoveries into Biologic Drugs in R&D: From Oncology to NeurologyLocation:254 AKeynote Speaker: – Alector
Moderator: – Repare Therapeutics
Preclinical Development – Biomolecular
Sara Kenkare-Mitra, PhD – Alector ### 1595386###Keynote Speaker###President, Head of Research & Development###Alector###Keynote Speaker: – Alector
### @@@ Adrian Fretland, PhD – Repare Therapeutics ### 1690833###Moderator###Executive Director, Head of Clinical Pharmacology and Toxicology###Repare Therapeutics###Moderator: – Repare Therapeutics
### 1:30 PM – 2:30 PM ET
Keynote: Prophylactic Therapies in Global Health Applications?Keynote Speaker: – Bill & Melinda Gates Foundation
Moderator: – University of Bath
Formulation and Delivery – Chemical
1:30 PM – 2:30 PM ET
Keynote: Prophylactic Therapies in Global Health Applications?Location:205 ABKeynote Speaker: – Bill & Melinda Gates Foundation
Moderator: – University of Bath
Formulation and Delivery – Chemical
Niya Bowers, PhD – Bill & Melinda Gates Foundation ### 1631286###Keynote Speaker###Senior Program Officer###Bill & Melinda Gates Foundation###Keynote Speaker: – Bill & Melinda Gates Foundation
### @@@ Nikoletta Fotaki, PhD – University of Bath ### 847632###Moderator###Reader in (Bio)Pharmaceutics###University of Bath###Moderator: – University of Bath
### 1:30 PM – 2:30 PM ET
Keynote: Redox Biology and Cancer TherapeuticsKeynote Speaker: – Medical University of South Carolina
Moderator: – University of Charleston
Discovery and Basic Research
1:30 PM – 2:30 PM ET
Keynote: Redox Biology and Cancer TherapeuticsLocation:255Keynote Speaker: – Medical University of South Carolina
Moderator: – University of Charleston
Discovery and Basic Research
Kenneth Tew, PHD, DSc, FASPET – Medical University of South Carolina ### 1596656###Keynote Speaker###Charir Pharmacology###Medical University of South Carolina###Keynote Speaker: – Medical University of South Carolina
### @@@ Tamer E. Fandy, PhD, BCGP, FCP – University of Charleston ### 1378497###Moderator###Professor & Chair, Department of Pharmaceutical & Adminstrative Sciences###University of Charleston###Moderator: – University of Charleston
### 1:30 PM – 2:30 PM ET
Keynote: The Future of Medicine is Here. Are We (Bioanalytically) Ready?Keynote Speaker: – Sana Biotechnology
Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
1:30 PM – 2:30 PM ET
Keynote: The Future of Medicine is Here. Are We (Bioanalytically) Ready?Location:253 BKeynote Speaker: – Sana Biotechnology
Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
Boris Gorovits, PhD – Sana Biotechnology ### 466045###Keynote Speaker###VP In vitro pharm and bioanalytical ###Sana Biotechnology ###Keynote Speaker: – Sana Biotechnology
### @@@ Lynn Kamen, PhD – BioAgilytix Labs ### 1680382###Moderator###Scientific Officer###BioAgilytix Labs###Moderator: – BioAgilytix Labs
### 1:30 PM – 2:30 PM ET
Long Acting Injectables- Predictive approaches in drug development and manufacturingManufacturing & Analytical Characterization
1:30 PM – 2:00 PM ET
Long Acting Injectables- Predictive approaches in drug development and manufacturingLocation:360 Stage #1, Exhibit Hall A&BManufacturing & Analytical Characterization
Sujatha Sonti, Dr – GSK ### 1743104###Partner Presentation Speaker###VP, Drug Product Development###GSK###Partner Presentation Speaker: – GSK
### @@@ Manish Gupta, PhD – GSK ### 1044965###Partner Presentation Speaker###Senior Director###GSK###Partner Presentation Speaker: – GSK
### @@@ Brian Rhodes, MS – GSK ### 466160###Partner Presentation Speaker###Sr. Director, Process Engineering and Analytics###GSK###Partner Presentation Speaker: – GSK
### 2:00 PM – 3:00 PM ET
Co-processed HPMC–mannitol: A directly compressible excipient for controlled releaseTech Spotlight Speaker: – Roquette America Inc.
Formulation and Delivery
2:00 PM – 3:00 PM ET
Co-processed HPMC–mannitol: A directly compressible excipient for controlled releaseLocation:360 Stage #2, Exhibit Hall A&BTech Spotlight Speaker: – Roquette America Inc.
Formulation and Delivery
Talles Ernica, MS – Roquette America Inc. ### 1743099###Tech Spotlight Speaker###Global Pharma Technical Developer###Roquette America Inc.###Tech Spotlight Speaker: – Roquette America Inc.
### 2:00 PM – 3:00 PM ET
Meet The Employers: Hosted by AstraZeneca
2:00 PM – 3:00 PM ET
Meet The Employer: Hosted by AstraZenecaLocation:Career Development Center, Exhibit Hall A&BCareer Development
2:00 PM – 3:00 PM ET
Serial Two-Photon Plus: Translating Ex Vivo to In Vivo ImagingTech Spotlight Speaker: – TissueVision Inc.
Preclinical Development
2:00 PM – 3:00 PM ET
Serial Two-Photon Plus: Translating Ex Vivo to In Vivo ImagingLocation:360 Stage #4, Exhibit Hall A&BTech Spotlight Speaker: – TissueVision Inc.
Preclinical Development
Stefan Linehan, MS – TissueVision Inc. ### 1764090###Tech Spotlight Speaker###VP of Operations and Development###TissueVision Inc.###Tech Spotlight Speaker: – TissueVision Inc.
### 2:30 PM – 3:00 PM ET
Coffee Break in the Solution Center
2:30 PM – 3:00 PM ET
Coffee Break in the Solution CenterLocation:Exhibit Hall A&B
2:30 PM – 3:30 PM ET
Hot Topic: Emerging Use of Real World Data to Address Data Gaps in Clinical Pharmacology: Opportunities & ChallengesHot Topic Moderator: – Pfizer
Hot Topic Speaker: – Premier Research
Hot Topic Speaker: – Metrum Research Group
Hot Topic Speaker: – Pfizer
Clinical Pharmacology
2:30 PM – 3:30 PM ET
Hot Topic: Emerging Use of Real World Data to Address Data Gaps in Clinical Pharmacology: Opportunities & ChallengesLocation:153 AHot Topic Moderator: – Pfizer
Hot Topic Speaker: – Premier Research
Hot Topic Speaker: – Metrum Research Group
Hot Topic Speaker: – Pfizer
Clinical Pharmacology
Simon Dagenais, PhD, MSc – Pfizer ### 1691797###Hot Topic Moderator###Senior director, RWE COE###Pfizer###Hot Topic Moderator: – Pfizer
### @@@ Abie Ekangaki, PhD – Premier Research ### 1691799###Hot Topic Speaker###Vice President, Statistical Consulting###Premier Research###Hot Topic Speaker: – Premier Research
### @@@ Marc Gastonguay, PhD – Metrum Research Group ### 1779523###Hot Topic Speaker###CEO###Metrum Research Group###Hot Topic Speaker: – Metrum Research Group
### @@@ Simon Dagenais, PhD, MSc – Pfizer ### 1691797###Hot Topic Speaker###Senior director, RWE COE###Pfizer###Hot Topic Speaker: – Pfizer
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Complex GenericsGovernment Speaker: – US Food and Drug Adminstration
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery
2:30 PM – 3:30 PM ET
Speaker Spotlight: Complex GenericsLocation:Spotlight Stage 3, Exhibit Hall A&BGovernment Speaker: – US Food and Drug Adminstration
Moderator: – Pfizer Worldwide Research and Development
Formulation and Delivery
Sam Raney, PhD – US Food and Drug Adminstration ### 604299###Government Speaker###Associate Director for Science###US Food and Drug Adminstration###Government Speaker: – US Food and Drug Adminstration
### @@@ Jaymin C. Shah, PhD – Pfizer Worldwide Research and Development ### 1554431###Moderator###Research Fellow and Head of Topical and Advanced Drug Delivery###Pfizer Worldwide Research and Development###Moderator: – Pfizer Worldwide Research and Development
### 2:30 PM – 3:30 PM ET
Speaker Spotlight: Understanding Clinical Immunogenicity Impact for a Bispecific Antibody AgonistSpotlight Speaker: – Genentech
Moderator: – Janssen R&D / J&J
Bioanalytics – Biomolecular
2:30 PM – 3:30 PM ET
Speaker Spotlight: Understanding Clinical Immunogenicity Impact for a Bispecific Antibody AgonistLocation:Spotlight Stage 2, Exhibit Hall A&BSpotlight Speaker: – Genentech
Moderator: – Janssen R&D / J&J
Bioanalytics – Biomolecular
Yanqiu (Emma) Liu, PhD – Genentech ### 1075489###Spotlight Speaker###Senior Principal Scientist###Genentech###Spotlight Speaker: – Genentech
### @@@ William Hallet, PhD (he/him/his) – Janssen R&D / J&J ### 1723662###Moderator###Associate Scientific Director###Janssen R&D / J&J###Moderator: – Janssen R&D / J&J
### he/him/his2:30 PM – 3:30 PM ET
Special Poster Collection
2:30 PM – 3:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – Purdue University
Tonglei Li, PhD – Purdue University ### 602266###Poster Collection Host###Professor###Purdue University###Poster Collection Host: – Purdue University
### 3:00 PM – 3:45 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Rapid Fire Moderator: – Sanofi
Manufacturing & Analytical Characterization – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (BM)Location:205 CRapid Fire Moderator: – Sanofi
Manufacturing & Analytical Characterization – Biomolecular
Jianmei D. Kochling, PhD, MBA – Sanofi ### 465971###Rapid Fire Moderator###Senior Director###Sanofi###Rapid Fire Moderator: – Sanofi
### 3:00 PM – 3:15 PM ET
Addressing Secondary Interactions in Size Exclusion Chromatography of Protein TherapeuticsLocation:205 CRapid Fire Speaker: – Waters Corporation
Manufacturing & Analytical Characterization – Biomolecular
Lavelay O. Kizekai – Waters Corporation ### 1755686###Rapid Fire Speaker###Sr. Scientist###Waters Corporation###Rapid Fire Speaker: – Waters Corporation
### 3:15 PM – 3:30 PM ET
High Polysorbate 80 in the Formulation Impacts the Structure and Function Assessment of Cation Exchange Fractions of a Monoclonal AntibodyLocation:205 CRapid Fire Speaker: – Merck
Manufacturing & Analytical Characterization – Biomolecular
Kaizhu Guo, PhD – Merck ### 1755923###Rapid Fire Speaker###Senior Scientist###Merck###Rapid Fire Speaker: – Merck
### 3:30 PM – 3:45 PM ET
Multi -Attribute-Monitoring (MAM) of Biopharmaceuticals Using High-Res QTOF Mass SpectrometryLocation:205 CRapid Fire Speaker: – Shimadzu Scientific Instruments Inc - Columbia, MD
Manufacturing & Analytical Characterization – Biomolecular
Mridul Mandal, PhD – Shimadzu Scientific Instruments Inc - Columbia, MD ### 1755679###Rapid Fire Speaker###Market Manager - Pharma/Biopharma###Shimadzu Scientific Instruments Inc - Columbia, MD###Rapid Fire Speaker: – Shimadzu Scientific Instruments Inc - Columbia, MD
### 3:00 PM – 3:45 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Rapid Fire Moderator: – Albany College of Pharmacy and Health Sciences
Preclinical Development – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (BM)Location:254 ARapid Fire Moderator: – Albany College of Pharmacy and Health Sciences
Preclinical Development – Biomolecular
HaiAn Zheng, PhD – Albany College of Pharmacy and Health Sciences ### 1755749###Rapid Fire Moderator###Associate Profession###Albany College of Pharmacy and Health Sciences ###Rapid Fire Moderator: – Albany College of Pharmacy and Health Sciences
### 3:00 PM – 3:15 PM ET
Positively Charged Surface in LIGHT Trimers Fused with Fc, a Ligand for Lymphotoxin-b Receptor (LTbR) and HVEM, Caused a Non-specific Interaction with Cells Leading to Fast Systemic Clearance in MiceLocation:254 ARapid Fire Speaker: – Genentech, Inc.
Preclinical Development – Biomolecular
Victor F. Yip, BS – Genentech, Inc. ### 848682###Rapid Fire Speaker###Principal Senior Scientific Researcher###Genentech, Inc.###Rapid Fire Speaker: – Genentech, Inc.
### 3:15 PM – 3:30 PM ET
More than the Sum of Its Parts: In Silico Immunogenicity Risk Assessment for Fusion Proteins and Novel Antibody ModalitiesLocation:254 ARapid Fire Speaker: – EpiVax, Inc.
Preclinical Development – Biomolecular
Frances Terry, MPH – EpiVax, Inc. ### 572017###Rapid Fire Speaker###Director of Analysis###EpiVax, Inc.###Rapid Fire Speaker: – EpiVax, Inc.
### 3:30 PM – 3:45 PM ET
Investigating Protein-Excipient Interactions Using NMR SpectroscopyLocation:254 ARapid Fire Speaker: – Merck & Co. Inc
Preclinical Development – Biomolecular
Jainik PANCHAL, PhD – Merck & Co. Inc ### 1755680###Rapid Fire Speaker###Associate Principal Scientist###Merck & Co. Inc###Rapid Fire Speaker: – Merck & Co. Inc
### 3:00 PM – 3:45 PM ET
Rapid Fire: Oncotargets: Challenges & OpportunitiesRapid Fire Moderator: – Husson University
Discovery and Basic Research
3:00 PM – 3:45 PM ET
Rapid Fire: Oncotargets: Challenges & OpportunitiesLocation:255Rapid Fire Moderator: – Husson University
Discovery and Basic Research
Muhammad D. Hussain, PhD (he/him/his) – Husson University ### 1794283###Rapid Fire Moderator###Professor of Pharmaceutics###Husson University###Rapid Fire Moderator: – Husson University
### he/him/his3:00 PM – 3:15 PM ET
Listeria-Based Vaccine Targeting Interferon-Stimulated Gene 15 for Renal Cell CarcinomaLocation:255Rapid Fire Speaker: – Texas Tech University Health Sciences Center
Discovery and Basic Research
HONG-MY NGUYEN – Texas Tech University Health Sciences Center ### 1689474###Rapid Fire Speaker###Ph.D. Student###Texas Tech University Health Sciences Center###Rapid Fire Speaker: – Texas Tech University Health Sciences Center
### 3:15 PM – 3:30 PM ET
Interaction with Macrophages Alters the Susceptibility of Cancer Cells to FerroptosisLocation:255Rapid Fire Speaker: – Osaka University
Discovery and Basic Research
Yuya Haga, PhD – Osaka University ### 1689734###Rapid Fire Speaker###Assistant Professor###Osaka University###Rapid Fire Speaker: – Osaka University
### 3:30 PM – 3:45 PM ET
Viral Mimicry NanoVaccine Boosting B Immunity to Enhance Anti-cancer EfficacyLocation:255Rapid Fire Speaker: – University of Michigan
Discovery and Basic Research
Chengyi Li, MS – University of Michigan ### 1689490###Rapid Fire Speaker###Graduate Student###University of Michigan###Rapid Fire Speaker: – University of Michigan
### 3:00 PM – 3:45 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (BM)Rapid Fire Moderator: – Auburn University
Formulation and Delivery – Biomolecular
3:00 PM – 3:45 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (BM)Location:204 ABRapid Fire Moderator: – Auburn University
Formulation and Delivery – Biomolecular
Jayachandra Babu Ramapuram, PhD (he/him/his) – Auburn University ### 847391###Rapid Fire Moderator###Professor###Auburn University###Rapid Fire Moderator: – Auburn University
### he/him/his3:00 PM – 3:15 PM ET
Towards a Bivalent-Microparticulate 3D-Printed Buccal Film-Based Universal Vaccine Against COVID-19Location:204 ABRapid Fire Speaker: – Mercer University College of Pharmacy
Formulation and Delivery – Biomolecular
Smital R. Patil, Bachelor of Pharmacy – Mercer University College of Pharmacy ### 1045776###Rapid Fire Speaker###Ph.D Candidate###Mercer University College of Pharmacy###Rapid Fire Speaker: – Mercer University College of Pharmacy
### 3:15 PM – 3:30 PM ET
Biotin Nanoparticles as Immune Cell Activator and Protein CarrierLocation:204 ABRapid Fire Speaker: – Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien
Formulation and Delivery – Biomolecular
Paul Hartmeier, BA – Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien ### 1045918###Rapid Fire Speaker###Graduate Student###Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien###Rapid Fire Speaker: – Duquesne University School of Pharmacy - Graduate School of Pharmaceutical Scien
### 3:30 PM – 3:45 PM ET
Redesigning Vaccine Delivery: Microneedle Vaccination for COVID-19 and InfluenzaLocation:204 ABRapid Fire Speaker: – Mercer University
Formulation and Delivery – Biomolecular
Sharon Vijayanand, B. Pharm – Mercer University ### 1045775###Rapid Fire Speaker###Ph.D. Candidate###Mercer University###Rapid Fire Speaker: – Mercer University
### 3:00 PM – 4:00 PM ET
A Look into the Future of BioanalyticsPartner Presentation Speaker: – Q2 Solutions
Partner Presentation Speaker: – Q2 Solutions
Bioanalytics
3:00 PM – 4:00 PM ET
A Look into the Future of BioanalyticsLocation:360 Stage #1, Exhibit Hall A&BPartner Presentation Speaker: – Q2 Solutions
Partner Presentation Speaker: – Q2 Solutions
Bioanalytics
Barry Jones, PhD – Q2 Solutions ### 466060###Partner Presentation Speaker###Director LC-MS Biologics & Biomarkers###Q2 Solutions###Partner Presentation Speaker: – Q2 Solutions
### @@@ Todd Lusk (he/him/his) – Q2 Solutions ### 1743100###Partner Presentation Speaker###Senior Scientist - Assay Development###Q2 Solutions###Partner Presentation Speaker: – Q2 Solutions
### he/him/his3:00 PM – 4:00 PM ET
Career Transitions Between Academia Industry and Regulatory AgencyCareer Center Moderator: – BMS
Career Center Speaker: – Department of Chemical and Biomolecular Engineering University of Maryland
Government Speaker:
Career Center Speaker: – Merck
Career Development
3:00 PM – 4:00 PM ET
Career Transitions Between Academia Industry and Regulatory AgencyLocation:360 Stage #3, Exhibit Hall A&BCareer Center Moderator: – BMS
Career Center Speaker: – Department of Chemical and Biomolecular Engineering University of Maryland
Government Speaker:
Career Center Speaker: – Merck
Career Development
Hiten J. Gutka, PhD – BMS ### 1650366###Career Center Moderator###Sr. Principal Scientist Drug Product Development###BMS###Career Center Moderator: – BMS
### @@@ Deborah S. Goldberg, PhD – Department of Chemical and Biomolecular Engineering University of Maryland ### 1650367###Career Center Speaker###Senior Lecturer Dept. of Chemical Engineering###Department of Chemical and Biomolecular Engineering University of Maryland###Career Center Speaker: – Department of Chemical and Biomolecular Engineering University of Maryland
### @@@ Rohit Kolhatkar ### 1699106###Government Speaker#########Government Speaker:
### @@@ Sachin Lohani, PhD – Merck ### 1477305###Career Center Speaker###Director###Merck###Career Center Speaker: – Merck
### 3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Alturas Analytics
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Alturas AnalyticsLocation:Booth #631, Exhibit Hall A&B
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by CoreRx
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by CoreRxLocation:Booth #230, Exhibit Hall A&B
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Gattefossé Corporation
3:00 PM – 4:00 PM ET
Happy Hour Sponsored by Gattefossé Corporation Location:Booth #216, Exhibit Hall A&BSponsored By Gattefossé Corp.
3:00 PM – 4:00 PM ET
Meet The Employers: Hosted by AbbVie
3:00 PM – 4:00 PM ET
Meet The Employer: Hosted by AbbVieLocation:Career Development Center, Exhibit Hall A&BCareer Development
3:00 PM – 4:00 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Rapid Fire Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Analytical and Predictive Approaches in Drug Development and Manufacturing (CE)Location:206 ABRapid Fire Moderator: – Merck & Co., Inc.
Manufacturing & Analytical Characterization – Chemical
Rosalind Ang, PhD – Merck & Co., Inc. ### 1762952###Rapid Fire Moderator###Associate Principal Scientist###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Advanced Microstructure Characterization of Extended-Release Claritin FormulationsLocation:206 ABRapid Fire Speaker: – DigiM Solution LLC
Manufacturing & Analytical Characterization – Chemical
Phillip D. Yawman, BS – DigiM Solution LLC ### 1689842###Rapid Fire Speaker###Senior Application Scientist###DigiM Solution LLC###Rapid Fire Speaker: – DigiM Solution LLC
### 3:15 PM – 3:30 PM ET
Coat Weight and Backing Membrane Effect on Adhesion of PatchesLocation:206 ABRapid Fire Speaker: – Florida A&M University
Manufacturing & Analytical Characterization – Chemical
Oluwaseyi Salau, BS – Florida A&M University ### 1690335###Rapid Fire Speaker###Graduate Student Researcher###Florida A&M University###Rapid Fire Speaker: – Florida A&M University
### 3:30 PM – 3:45 PM ET
Material-Sparing Assessment of the Manufacturability of Long Acting Injectable SuspensionsLocation:206 ABRapid Fire Speaker: – GlaxoSmithKline
Manufacturing & Analytical Characterization – Chemical
Parind Desai, PhD – GlaxoSmithKline ### 1650328###Rapid Fire Speaker###Scientific Leader, GSK Fellow###GlaxoSmithKline###Rapid Fire Speaker: – GlaxoSmithKline
### 3:45 PM – 4:00 PM ET
Potential Impact of the EU TiO2 Food Ban on PharmaceuticalsLocation:206 ABRapid Fire Speaker: – Black Diamond Regulatory Consulting/IPEC-Americas
Manufacturing & Analytical Characterization – Chemical
David R. Schoneker, M.S. – Black Diamond Regulatory Consulting/IPEC-Americas ### 1011741###Rapid Fire Speaker###President/Owner/Consultant & Vice Chair of IPEC-Americas QbD Committee###Black Diamond Regulatory Consulting/IPEC-Americas###Rapid Fire Speaker: – Black Diamond Regulatory Consulting/IPEC-Americas
### 3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Rapid Fire Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (BM)Location:253 BRapid Fire Moderator: – BioAgilytix Labs
Bioanalytics – Biomolecular
Chad J. Briscoe, PhD – BioAgilytix Labs ### 605822###Rapid Fire Moderator###Scientific Officer / VP Business Development Europe###BioAgilytix Labs###Rapid Fire Moderator: – BioAgilytix Labs
### 3:00 PM – 3:15 PM ET
Qualified RT-qPCR Assays to Measure Transgene and Target Gene ExpressionLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Yanmei Lu, PhD – Sangamo Therapeutics ### 1650349###Rapid Fire Speaker###VP of Biomarker and BioAnalytical Sciences###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:15 PM – 3:30 PM ET
Assay Optimization to Detect Treatment-Boosted Neutralizing Anti-Transgene Antibodies in PatientsLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Joshua Holter – Sangamo Therapeutics ### 1755695###Rapid Fire Speaker###BioAnalytical Scientist###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:30 PM – 3:45 PM ET
Acceptable Level of Precision in qPCR Assay ValidationsLocation:253 BRapid Fire Speaker: – Eurofins-Viracor
Bioanalytics – Biomolecular
Mark C. Wissel, PhD – Eurofins-Viracor ### 1651144###Rapid Fire Speaker###Director, R&D###Eurofins-Viracor###Rapid Fire Speaker: – Eurofins-Viracor
### 3:45 PM – 4:00 PM ET
Detecting Species-Specific Cytosolic Transgene Protein Supporting Liver Gene Therapy StudiesLocation:253 BRapid Fire Speaker: – Sangamo Therapeutics
Bioanalytics – Biomolecular
Joshua Holter – Sangamo Therapeutics ### 1755695###Rapid Fire Speaker###BioAnalytical Scientist###Sangamo Therapeutics###Rapid Fire Speaker: – Sangamo Therapeutics
### 3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Rapid Fire Moderator: – BioAgilytix
Bioanalytics – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Beyond Legacy Therapeutics - Navigating the Path Less Traveled (CE)Location:253 ARapid Fire Moderator: – BioAgilytix
Bioanalytics – Chemical
Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Rapid Fire Moderator###Scientific Officer###BioAgilytix###Rapid Fire Moderator: – BioAgilytix
### 3:00 PM – 3:15 PM ET
Quantitation of Dystrophin and Microdystrophin by A Hybrid LBA/LC-MS AssayLocation:253 ARapid Fire Speaker: – REGENXBIO, Inc.
Bioanalytics – Chemical
Hua Wang, PhD – REGENXBIO, Inc. ### 1447044###Rapid Fire Speaker###Sr Scientist###REGENXBIO, Inc.###Rapid Fire Speaker: – REGENXBIO, Inc.
### 3:15 PM – 3:30 PM ET
The Bioanalysis of ADC Therapeutics in Monkey Serum by IC-LC-MS in the Lead Nomination Stage Location:253 ARapid Fire Speaker: – WuXi AppTec
Bioanalytics – Chemical
Jim Yamashita, PhD – WuXi AppTec ### 1650378###Rapid Fire Speaker###Senior Director, Small Molecule Bioanalysis###WuXi AppTec###Rapid Fire Speaker: – WuXi AppTec
### 3:30 PM ET
Is Hybrid LC-MS/MS Becoming The New Gold Standard? Unique Case Studies Highlighting the Power of Hybrid LCMS – ADCs, MAbs and Other Protein Therapeutics Location:253 ARapid Fire Speaker: – KCAS
Bioanalytics – Chemical
Dawn Dufield, PhD – KCAS ### 466205###Rapid Fire Speaker###Senior Director Biopharma Services - LC-MS/MS###KCAS###Rapid Fire Speaker: – KCAS
### 3:45 PM – 4:00 PM ET
Immunocapture and Tryptic Digest for Quantitation of a Biomarker in Monkey SerumLocation:253 ARapid Fire Speaker: – Bioagilytix
Bioanalytics – Chemical
Christian Smith (he/him/his) – Bioagilytix ### 1791680###Rapid Fire Speaker###Scientist###Bioagilytix###Rapid Fire Speaker: – Bioagilytix
### he/him/his3:00 PM – 4:00 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Rapid Fire Moderator: – Takeda
Preclinical Development – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Bridging The Cross-Functional Silos To Expedite Compound Progression Into The Clinic (CE)Location:253 CRapid Fire Moderator: – Takeda
Preclinical Development – Chemical
Haiqing Wang, PhD – Takeda ### 1650380###Rapid Fire Moderator###Director###Takeda###Rapid Fire Moderator: – Takeda
### 3:00 PM – 3:15 PM ET
Cannabidiol Loaded Extracellular Vesicles Alleviate Paclitaxel Induced Peripheral NeuropathyLocation:253 CRapid Fire Speaker: – Florida A&M University
Preclinical Development – Chemical
Mandip S. Sachdeva, PhD – Florida A&M University ### 848734###Rapid Fire Speaker###Professor###Florida A&M University###Rapid Fire Speaker: – Florida A&M University
### 3:15 PM – 3:30 PM ET
Enabling Preclinical Bioperformance Prediction Through Data AnalyticsLocation:253 CRapid Fire Speaker: – Merck & Co, Inc.
Preclinical Development – Chemical
Pierre Daublain, PhD – Merck & Co, Inc. ### 1755700###Rapid Fire Speaker###Principal Scientist###Merck & Co, Inc.###Rapid Fire Speaker: – Merck & Co, Inc.
### 3:30 PM – 3:45 PM ET
Using the Dynamic Gastric Model (DGM) to Predict Food EffectsLocation:253 CRapid Fire Speaker: – Bioneer A/S
Preclinical Development – Chemical
Matthias M. Knopp, PhD – Bioneer A/S ### 606140###Rapid Fire Speaker###Principal Scientist###Bioneer A/S###Rapid Fire Speaker: – Bioneer A/S
### 3:45 PM – 4:00 PM ET
Small Molecule Crystallographic and Modeling Strategies to Improve SolubilityLocation:253 CRapid Fire Speaker: – Merck
Preclinical Development – Chemical
Tina Xiong, PhD – Merck ### 1755667###Rapid Fire Speaker###Associate Principal Scientist###Merck###Rapid Fire Speaker: – Merck
### 3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)Rapid Fire Moderator: – Johnson and Johnson
Clinical Pharmacology – Biomolecular
3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (BM)Location:152Rapid Fire Moderator: – Johnson and Johnson
Clinical Pharmacology – Biomolecular
Hardik Mody, PhD – Johnson and Johnson ### 1010836###Rapid Fire Moderator###Principal Scientist###Johnson and Johnson###Rapid Fire Moderator: – Johnson and Johnson
### 3:00 PM – 3:15 PM ET
Clinical Pharmacology in COVID-19 Drug Development: Remaining Agile During a Public Health EmergencyLocation:152Rapid Fire Speaker: – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA
Clinical Pharmacology – Biomolecular
Kellie S. Reynolds, PharmD – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA ### 796154###Rapid Fire Speaker###Division Director###Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA###Rapid Fire Speaker: – Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, OTS, CDER, FDA
### 3:15 PM – 3:30 PM ET
Drug Interactions with PaxlovidLocation:152Rapid Fire Speaker: – Pfizer
Clinical Pharmacology – Biomolecular
Bharat Damle, PhD – Pfizer ### 845568###Rapid Fire Speaker###Executive Director###Pfizer###Rapid Fire Speaker: – Pfizer
### 3:30 PM – 3:45 PM ET
Challenges in Dose Adjustment for a SARS COV-2 Variant Based on in-vitro Neutralization DataLocation:152Rapid Fire Speaker: – Regeneron Pharmaceuticals
Clinical Pharmacology – Biomolecular
Kenneth Turner, PhD – Regeneron Pharmaceuticals ### 1650345###Rapid Fire Speaker###Sr Group Director, Clinical Pharmacology###Regeneron Pharmaceuticals###Rapid Fire Speaker: – Regeneron Pharmaceuticals
### 3:45 PM – 4:00 PM ET
Rethinking the Role of Clinical Pharmacology in a Systems Perspective to Accelerate Biologics (mAbs, Cytokine Modulator) Development Location:152Rapid Fire Speaker: – Center for WE-REACH
Clinical Pharmacology – Biomolecular
Rodney J. Ho, Ph.D NAI FAAPS FAAAS – Center for WE-REACH ### 1046065###Rapid Fire Speaker###Executive Director and Professor###Center for WE-REACH###Rapid Fire Speaker: – Center for WE-REACH
### 3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Rapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: COVID Pandemic and Beyond: Role of Clinical Pharmacology in Development of Non-COVID and COVID Drugs (CE)Location:151 ABRapid Fire Moderator: – Agios Pharmaceuticals
Clinical Pharmacology – Chemical
Punit Marathe, PhD – Agios Pharmaceuticals ### 1010799###Rapid Fire Moderator###Vice President DMPK-TOX###Agios Pharmaceuticals###Rapid Fire Moderator: – Agios Pharmaceuticals
### 3:00 PM – 3:15 PM ET
19F-NMR as a Tool for Paxlovid ADME Studies Location:151 ABRapid Fire Speaker: – Pfizer
Clinical Pharmacology – Chemical
Arthur Bergman, PhD (he/him/his) – Pfizer ### 1800096###Rapid Fire Speaker###Clinical Pharmacology Group Head - Anti-infectives, Early Clinical Development ###Pfizer###Rapid Fire Speaker: – Pfizer
### he/him/his3:15 PM – 3:30 PM ET
Paxlovid Dose Recommendations in Special PopulationsLocation:151 ABRapid Fire Speaker: – Pfizer
Clinical Pharmacology – Chemical
Donna S. Cox, PhD – Pfizer ### 1755874###Rapid Fire Speaker###Senior Director, Clinical Pharmacology Group Lead; Global Product Development###Pfizer###Rapid Fire Speaker: – Pfizer
### 3:30 PM – 3:45 PM ET
Rapid Repurposing of a QSP Platform to Guide COVID-19 Vaccine DevelopmentLocation:151 ABRapid Fire Speaker: – Certara
Clinical Pharmacology – Chemical
Piet H. van der Graaf, PharmD, PhD – Certara ### 1308013###Rapid Fire Speaker###Senior Vice President QSP###Certara###Rapid Fire Speaker: – Certara
### 3:45 PM – 4:00 PM ET
Rethinking the Role of Clinical Pharmacology in a Systems Perspective to Accelerate Small Molecules (Entry, Protease and Polymerase Inhibitors) Development Location:151 ABRapid Fire Speaker: – University of Washington
Clinical Pharmacology – Chemical
Simone Perazzolo, PhD – University of Washington ### 1695214###Rapid Fire Speaker###Scientist###University of Washington###Rapid Fire Speaker: – University of Washington
### 3:00 PM – 4:00 PM ET
Rapid Fire: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesRapid Fire Moderator: – Novartis Institutes for Biomedical Research
Discovery and Basic Research
3:00 PM – 4:00 PM ET
Rapid Fire: Rapid Discovery of Therapeutics: Past Experience and Computational ApproachesLocation:254 BRapid Fire Moderator: – Novartis Institutes for Biomedical Research
Discovery and Basic Research
Ryan Polli, PhD – Novartis Institutes for Biomedical Research ### 1777897###Rapid Fire Moderator###Principal Scientist II - Pharmacokinetic Sciences###Novartis Institutes for Biomedical Research###Rapid Fire Moderator: – Novartis Institutes for Biomedical Research
### 3:00 PM – 3:15 PM ET
Deep Learned Screenings of Peptide Vaccines for Exosome-Based Precision DeliveryLocation:254 BRapid Fire Speaker: – University of Florida
Discovery and Basic Research
Zachary Greenberg, MS – University of Florida ### 1328730###Rapid Fire Speaker###Doctoral Student###University of Florida###Rapid Fire Speaker: – University of Florida
### 3:15 PM – 3:30 PM ET
Early Feasibility Assessment of Biotherapeutics Dosing RequirementsLocation:254 BRapid Fire Speaker: – Applied BioMath
Discovery and Basic Research
Fei Hua, PhD – Applied BioMath ### 624501###Rapid Fire Speaker###VP of Modeling and Simulation Services###Applied BioMath###Rapid Fire Speaker: – Applied BioMath
### 3:30 PM – 3:45 PM ET
Personalized Prediction of FDA Approved Drugs with AI/ML for Precision Oncology ApplicationsLocation:254 BDiscovery and Basic Research
Jake Chen ### 1768512###Rapid Fire Speaker#########Rapid Fire Speaker:
### 3:00 PM – 4:00 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (CE)Rapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
3:00 PM – 4:00 PM ET
Rapid Fire: Recent Development in Prophylactic Therapies and Vaccines (CE)Location:205 ABRapid Fire Moderator: – Merck & Co., Inc.
Formulation and Delivery – Chemical
Suman A. Luthra, PhD – Merck & Co., Inc. ### 1689830###Rapid Fire Moderator###Director###Merck & Co., Inc.###Rapid Fire Moderator: – Merck & Co., Inc.
### 3:00 PM – 3:15 PM ET
Enzyme-Responsive Peptide Hydrogels as Long-Acting Injectable Implants for HIV/AIDS PreventionLocation:205 ABRapid Fire Speaker: – Queen's University Belfast
Formulation and Delivery – Chemical
Garry Laverty, MPharm PhD – Queen's University Belfast ### 1755682###Rapid Fire Speaker###Associate Professor in Pharmaceutical Sciences###Queen's University Belfast###Rapid Fire Speaker: – Queen's University Belfast
### 3:15 PM – 3:30 PM ET
Inhaled Clofazimine Particles: An Important Tool Against Mycobacterial Lung InfectionsLocation:205 ABRapid Fire Speaker: – University of Michigan
Formulation and Delivery – Chemical
Ashlee D. Brunaugh, Pharm.D. PhD – University of Michigan ### 1755701###Rapid Fire Speaker###Assistant Professor###University of Michigan###Rapid Fire Speaker: – University of Michigan
### 3:30 PM – 3:45 PM ET
Inhaled Delivery of Lung Cancer Therapeutics for Optimizing Local DosingLocation:205 ABRapid Fire Speaker: – Lonza Pharma & Biotech
Formulation and Delivery – Chemical
David K. Lyon, PhD – Lonza Pharma & Biotech ### 870066###Rapid Fire Speaker###Sr. Fellow, Research (Lonza Bend)###Lonza Pharma & Biotech###Rapid Fire Speaker: – Lonza Pharma & Biotech
### 3:45 PM – 4:00 PM ET
Oral delivery of Amphotericin B by Lipid-Based Drug Delivery SystemsLocation:205 ABRapid Fire Speaker: – University of Copenhagen
Formulation and Delivery – Chemical
Anette Mullertz, PhD – University of Copenhagen ### 466033###Rapid Fire Speaker###Professor###University of Copenhagen###Rapid Fire Speaker: – University of Copenhagen
### 3:00 PM – 4:00 PM ET
Start-up Pavilion Meet & Greet and New England Brewery Tour
3:00 PM – 4:00 PM ET
Start-up Pavilion Meet & Greet and New England Brewery TourLocation:Start-up Pavilion (Aisle 1500), Exhibit Hall A&B
3:30 PM – 4:30 PM ET
A Patient Centric Solution for Development of Oral Dosage FormsPartner Presentation Speaker: – Catalent, Inc.
Formulation and Delivery
3:30 PM – 4:30 PM ET
A Patient Centric Solution for Development of Oral Dosage FormsLocation:360 Stage #2, Exhibit Hall A&BPartner Presentation Speaker: – Catalent, Inc.
Formulation and Delivery
Karunakar Sukuru, PhD – Catalent, Inc. ### 1690085###Partner Presentation Speaker###Vice President- Product Development -Pharma Product Delivery###Catalent, Inc.###Partner Presentation Speaker: – Catalent, Inc.
### 3:30 PM – 4:30 PM ET
Happy Hour Sponsored by WuXi AppTec
3:30 PM – 4:30 PM ET
Happy Hour Sponsored by WuXi AppTecLocation:Booth #723, Exhibit Hall A&B
3:30 PM – 4:30 PM ET
Hot Topic: Learnings From Managing Immunogenicity Risks to Protein Based Therapeutics; Need to Pivot for Cell and Gene Therapies or 1 Size Fits All?Hot Topic Moderator: – Epivax
Preclinical Development – Biomolecular
3:30 PM – 4:30 PM ET
Hot Topic: Learnings From Managing Immunogenicity Risks to Protein Based Therapeutics; Need to Pivot for Cell and Gene Therapies or 1 Size Fits All?Location:153 BCHot Topic Moderator: – Epivax
Preclinical Development – Biomolecular
Amy S. Rosenberg, MD – Epivax ### 567446###Hot Topic Moderator###Senior Director of Immunology ###Epivax###Hot Topic Moderator: – Epivax
### 3:30 PM – 3:45 PM ET
Deimmunization and Immune Tolerance Strategies for Protein Therapeutics: Extension of Principles to Novel Therapeutic Modalities.Location:153 BCHot Topic Speaker: – EpiVax, Inc.
Preclinical Development – Biomolecular
Anne De Groot, MD – EpiVax, Inc. ### 1447113###Hot Topic Speaker###CEO/CSO###EpiVax, Inc.###Hot Topic Speaker: – EpiVax, Inc.
### 3:45 PM – 4:00 PM ET
Preclinical and Clinical Immunogenicity Risk Mitigation and Management for CAR-T TherapiesLocation:153 BCHot Topic Speaker: – Bristol Myers Squibb
Preclinical Development – Biomolecular
Vibha Jawa, Ph.D., FAAPS – Bristol Myers Squibb ### 567586###Hot Topic Speaker###Executive Director###Bristol Myers Squibb###Hot Topic Speaker: – Bristol Myers Squibb
### 4:00 PM – 4:15 PM ET
Enhancing Engraftment of Hematopoietic Stem Cells Using CD117-Saporin Immunotoxin: Advantages in Gene Therapy, Allotransplantation and Tolerance InductionLocation:153 BCGovernment Speaker: – NIAID, NIH
Preclinical Development – Biomolecular
Philip Murphy, MD – NIAID, NIH ### 1686558###Government Speaker###Chief, Laboratory of Molecular Immunology###NIAID, NIH###Government Speaker: – NIAID, NIH
### 4:15 PM – 4:30 PM ET
Panel DiscussionLocation:153 BCHot Topic Moderator: – Epivax
Hot Topic Speaker: – EpiVax, Inc.
Government Speaker: – NIAID, NIH
Hot Topic Speaker: – Bristol Myers Squibb
Preclinical Development – Biomolecular
Amy S. Rosenberg, MD – Epivax ### 567446###Hot Topic Moderator###Senior Director of Immunology ###Epivax###Hot Topic Moderator: – Epivax
### @@@ Anne De Groot, MD – EpiVax, Inc. ### 1447113###Hot Topic Speaker###CEO/CSO###EpiVax, Inc.###Hot Topic Speaker: – EpiVax, Inc.
### @@@ Philip Murphy, MD – NIAID, NIH ### 1686558###Government Speaker###Chief, Laboratory of Molecular Immunology###NIAID, NIH###Government Speaker: – NIAID, NIH
### @@@ Vibha Jawa, Ph.D., FAAPS – Bristol Myers Squibb ### 567586###Hot Topic Speaker###Executive Director###Bristol Myers Squibb###Hot Topic Speaker: – Bristol Myers Squibb
### 3:30 PM – 4:30 PM ET
Special Poster Collection
3:30 PM – 4:30 PM ET
Special Poster CollectionLocation:Poster Forum #2, Exhibit Hall A&BPoster Collection Host: – AstraZeneca
Poster Collection Host: – AstraZeneca Pharmaceuticals
Annette Bak, PhD, MBA, FAAPS (she/her/hers) – AstraZeneca ### 466184###Poster Collection Host###Executive Director###AstraZeneca###Poster Collection Host: – AstraZeneca
### she/her/hers @@@ Wenzhan Yang, PhD – AstraZeneca Pharmaceuticals ### 1755694###Poster Collection Host###Associate Principal Scientist###AstraZeneca Pharmaceuticals###Poster Collection Host: – AstraZeneca Pharmaceuticals
### 3:30 PM – 4:30 PM ET
Using HME for Low-Cost, High-Volume, Excipient-Enabled Antimalarials for Underserved PopulationsPartner Presentation Speaker: – Queen’s University Belfast
Partner Presentation Speaker: – Rondol Industrie
Partner Presentation Speaker: – BASF Corporation
Formulation and Delivery
3:30 PM – 4:30 PM ET
Using HME for Low-Cost, High-Volume, Excipient-Enabled Antimalarials for Underserved PopulationsLocation:360 Stage #4, Exhibit Hall A&BPartner Presentation Speaker: – Queen’s University Belfast
Partner Presentation Speaker: – Rondol Industrie
Partner Presentation Speaker: – BASF Corporation
Formulation and Delivery
Gavin P. Andrews, PhD (he/him/his) – Queen’s University Belfast ### 602480###Partner Presentation Speaker###Professor Pharmaceutical Engineering###Queen’s University Belfast###Partner Presentation Speaker: – Queen’s University Belfast
### he/him/his @@@ Victoire de Margerie, PhD – Rondol Industrie ### 1743102###Partner Presentation Speaker###Executive Chairman###Rondol Industrie###Partner Presentation Speaker: – Rondol Industrie
### @@@ Lindsay M. Johnson, PhD – BASF Corporation ### 1137450###Partner Presentation Speaker###Global Technical Marketing Manager###BASF Corporation###Partner Presentation Speaker: – BASF Corporation
### 3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Adare Pharma Solutions
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Adare Pharma SolutionsLocation:Booth #929, Exhibit Halls A & BSponsored By Adare Pharma
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Boston Analytical
3:45 PM – 4:45 PM ET
Happy Hour Sponsored by Boston AnalyticalLocation:Booth #1209, Exhibit Hall A&BSponsored By Boston Analytical
4:00 PM – 5:00 PM ET
AAPS Pharmacometrics Community Membership Meeting
4:00 PM – 5:00 PM ET
AAPS Pharmacometrics Community Membership Meeting Location:Spotlight Stage 1, Exhibit Hall A&B
Dipti Pawaskar ### 1779176###Community Leader#########Community Leader:
### 4:00 PM – 5:00 PM ET
AAPS Women in Pharmaceutical Science Community Membership Meeting Community Leader: – PPD Laboratories
4:00 PM – 5:00 PM ET
AAPS Women in Pharmaceutical Science Community Membership Meeting Location:Spotlight Stage 2, Exhibit Hall A&BCommunity Leader: – PPD Laboratories
Amy Lavelle, PhD (she/her/hers) – PPD Laboratories ### 802454###Community Leader###Director###PPD Laboratories###Community Leader: – PPD Laboratories
### she/her/hers5:00 PM – 6:00 PM ET
AAPS Biomarkers & Precision Medicine Community Membership MeetingCommunity Leader: – BioAgilytix
5:00 PM – 6:00 PM ET
AAPS Biomarkers & Precision Medicine Community Membership MeetingLocation:253 BCommunity Leader: – BioAgilytix
Amanda Hays, Ph.D. – BioAgilytix ### 1529523###Community Leader###Scientific Officer###BioAgilytix###Community Leader: – BioAgilytix
### 5:00 PM – 6:00 PM ET
AAPS Gene & Cell Therapy Products Community Membership MeetingCommunity Leader: – Johnson and Johnson
5:00 PM – 6:00 PM ET
AAPS Gene & Cell Therapy Products Community Membership MeetingLocation:253 ACommunity Leader: – Johnson and Johnson
Prathap Nagaraja Shastri, PhD – Johnson and Johnson ### 567445###Community Leader###Scientific Director###Johnson and Johnson ###Community Leader: – Johnson and Johnson
### 5:00 PM – 6:00 PM ET
AAPS Global Health Community Membership MeetingCommunity Leader: – Bill & Melinda Gates Medical Research Institute
5:00 PM – 6:00 PM ET
AAPS Global Health Community Membership MeetingLocation:255Community Leader: – Bill & Melinda Gates Medical Research Institute
Joleen T. White, PhD – Bill & Melinda Gates Medical Research Institute ### 627094###Community Leader###Head of Bioassay Development and Operations###Bill & Melinda Gates Medical Research Institute###Community Leader: – Bill & Melinda Gates Medical Research Institute
### 5:00 PM – 6:00 PM ET
AAPS In Vitro Release & Dissolution Testing Community Membership MeetingCommunity Leader: – Merck & Co., Inc.
5:00 PM – 6:00 PM ET
AAPS In Vitro Release & Dissolution Testing Community Membership MeetingLocation:253 CCommunity Leader: – Merck & Co., Inc.
Andre Hermans, PhD – Merck & Co., Inc. ### 624038###Community Leader###Director###Merck & Co., Inc.###Community Leader: – Merck & Co., Inc.
### 5:00 PM – 6:00 PM ET
AAPS Inhalation & Nasal Community Membership MeetingCommunity Leader: – St. John's University
5:00 PM – 6:00 PM ET
AAPS Inhalation & Nasal Community Membership MeetingLocation:153 ACommunity Leader: – St. John's University
Vivek Gupta, PhD – St. John's University ### 604838###Community Leader###Associate Professor, Pharmaceutical Sciences###St. John's University###Community Leader: – St. John's University
### 5:00 PM – 6:00 PM ET
AAPS Oral Biopharmaceutics & Absorption Modeling Community Membership MeetingCommunity Leader: – University of Bath
5:00 PM – 6:00 PM ET
AAPS Oral Biopharmaceutics & Absorption Modeling Community Membership MeetingLocation:254 BCommunity Leader: – University of Bath
Nikoletta Fotaki, PhD – University of Bath ### 847632###Community Leader###Reader in (Bio)Pharmaceutics###University of Bath###Community Leader: – University of Bath
### 5:00 PM – 6:00 PM ET
AAPS Protein Purification, Storage, Transportation, and Drug-Device Combination Community Membership MeetingCommunity Leader: – Drug Product Development / Bristol Myers Squibb
5:00 PM – 6:00 PM ET
AAPS Protein Purification, Storage, Transportation, and Drug-Device Combination Community Membership MeetingLocation:254 ACommunity Leader: – Drug Product Development / Bristol Myers Squibb
Mary E. Krause, Ph.D. – Drug Product Development / Bristol Myers Squibb ### 893994###Community Leader###Principal Scientist###Drug Product Development / Bristol Myers Squibb###Community Leader: – Drug Product Development / Bristol Myers Squibb
### 5:00 PM – 6:00 PM ET
AAPS Stability Community Membership Meeting
5:00 PM – 6:00 PM ET
AAPS Stability Community Membership MeetingLocation:153 BC
5:00 PM – 6:00 PM ET
AAPS Sterile Products Community Membership MeetingCommunity Leader: – Merck & Co., Inc.,
5:00 PM – 6:00 PM ET
AAPS Sterile Products Community Membership MeetingLocation:152Community Leader: – Merck & Co., Inc.,
Smeet Deshmukh, Ph.D. – Merck & Co., Inc., ### 803606###Community Leader###Principal Scientist###Merck & Co., Inc.,###Community Leader: – Merck & Co., Inc.,
### 5:00 PM – 6:00 PM ET
AAPS Therapeutic Product Immunogenicity Community Membership MeetingCommunity Leader: – Eli Lilly and Company
5:00 PM – 6:00 PM ET
AAPS Therapeutic Product Immunogenicity Community Membership MeetingLocation:151 ABCommunity Leader: – Eli Lilly and Company
Yi Wen, PhD – Eli Lilly and Company ### 1011767###Community Leader###Director###Eli Lilly and Company###Community Leader: – Eli Lilly and Company
### 5:00 PM – 7:00 PM ET
University of Kansas Pharmaceutical Chemistry Alumni Reception (Invitation Only)
5:00 PM – 7:00 PM ET
University of Kansas Pharmaceutical Chemistry Alumni Reception (Invitation Only)Location:Alcott Room, Westin Boston Seaport District Hotel
5:00 PM – 7:00 PM ET
University of Michigan College of Pharmacy Alumni and Friends Reception
5:00 PM – 7:00 PM ET
University of Michigan College of Pharmacy Alumni and Friends ReceptionLocation:Burroughs Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
Minnesota Alumni Reception
5:30 PM – 7:30 PM ET
Minnesota Alumni ReceptionLocation:Douglas Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Alumni Reception
5:30 PM – 7:30 PM ET
University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Alumni ReceptionLocation:Lewis Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
University of Texas - Austin, College of Pharmacy Alumni & Friends Reception
5:30 PM – 7:30 PM ET
University of Texas - Austin, College of Pharmacy Alumni & Friends ReceptionLocation:Fanueil Room, Westin Boston Seaport District Hotel
5:30 PM – 7:30 PM ET
University of Wisconsin-Madison Alumni & Friends Reception
5:30 PM – 7:30 PM ET
University of Wisconsin-Madison Alumni & Friends ReceptionLocation:Mediterranean Room, Renaissance
5:30 PM – 8:00 PM ET
University of Utah Pharmaceutics & Pharmaceutical Chemistry/Molecular Pharmaceutics Alumni Event
5:30 PM – 8:00 PM ET
University of Utah Pharmaceutics & Pharmaceutical Chemistry/Molecular Pharmaceutics Alumni EventLocation:Griffin Room, Westin Boston Seaport District Hotel
6:00 PM – 8:00 PM ET
2022 AAPS OSU Alumni and Friends Reception (Invitation Only)
6:00 PM – 8:00 PM ET
2022 AAPS OSU Alumni and Friends Reception (Invitation Only)Location:The Committee, 50 Northern Ave, Boston, MA 02210
6:00 PM – 8:00 PM ET
Purdue University College of Pharmacy Alumni and Friends Reception
6:00 PM – 8:00 PM ET
Purdue University College of Pharmacy Alumni and Friends ReceptionLocation:City Tap House Boston, 10 Boston Wharf Rd, Boston, MA 02210
6:00 PM – 8:00 PM ET
St. John's College of Pharmacy and Health Sciences
6:00 PM – 8:00 PM ET
St. John's College of Pharmacy and Health Sciences Location:Atlantic 3, Renaissance Boston Waterfront
6:00 PM – 9:00 PM ET
Vietnamese Association of Pharmaceutical Scientists
6:00 PM – 9:00 PM ET
Vietnamese Association of Pharmaceutical Scientists
Location:Phở Pasteur, 682 Washington St, Boston, MA, 02111
7:00 PM – 9:00 PM ET
President's Reception (by invitation only)
7:00 PM – 9:00 PM ET
President's Reception (by invitation only)Location:New England Aquarium
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)